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Abstract 
ADP-ribosylation is one of many biologically significant protein post-translational 
modifications (PTMs) that received considerable research interest in the past decade.  The 
first part of this work presents the analysis of ADP-ribosylation, with special focus on the 
catalytic domain of the enzyme ARTD-10.  The application of capillary electrophoresis (CE) 
is proposed in this work to separate the in vitro enzymatic mono-ADP-ribosylated ARTD-10 
catalytic domain and its unmodified form. 
Another important aspect of CE is sample preparation.  The effectiveness and 
efficiency for in-vial reaction, in-capillary mixing reaction and on-capillary-tip reaction by 
performing methyl esterification on phophopeptides were investigated, in the context of sub-
microliter sample handling in an attempt to provide insight into the integration of such in-
capillary derivatization with sample enrichment step in the near future.  In this work, a 
miniaturized in-capillary methyl esterification method was developed, allowing the efficient 
sample handling of sub-µL quantities as a scaled-down sample preparation approach. 
Keywords 
capillary electrophoresis, proteins, peptides, ADP-ribosylation, ARTD-10, phosphorylation, 
mass spectrometry, sample preparation, sub-microliter volume, derivatization, methyl 
esterification 
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Chapter 1. Introduction 
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1.1 Protein Post-Translational Modifications 
Life is defined by the intricate interplay of a diversity of biomolecules, the 
naturally occurring molecules that are found in or more accurately, produced by living 
organisms.  Among various types of biomolecules, peptides and proteins play a 
profoundly significant role in the regulation of many vital processes and therefore are 
considered as the most important biologically active substances.  Hence, the study of 
proteins and peptides are of great research interest. 
1.1.1 General Remarks 
The three-dimensional (3D) protein structure is predominantly determined by the 
primary sequence (linear alignment of the constituent amino acid residues), which is 
dictated by the genetic code, while the real-time dynamics and structural, functional 
diversity of proteins are generally modulated by the incorporation of different 
modifications.
1
  As two important building blocks of life, DNA and protein lead pivotal 
roles in a diversity of biological processes.  During gene expression, the information 
(genetic code) stored in DNA is transcribed onto messenger RNA (mRNA), then is 
passed onto transfer RNA (tRNA) via translation and used for the biosynthesis of 
functional gene products, most commonly proteins.  As the central dogma of molecular 
biology (Figure 1.1) proposes, the transcription of DNA together with the translation of 
RNA contributes to the final synthesis of proteins. 
3 
 
 
Figure 1.1 Schematic representation of central dogma of molecular biology. 
Post-translational modification (PTM), as the name indicates, is the chemical 
alteration to the structure of a protein among the last steps in the protein biosynthesis, 
namely translation.  To be more specific, PTM denotes changes in the polypeptide chain 
resulting from either the addition or removal of distinct chemical moieties to amino acid 
residues, proteolytic cleavage, or the introduction of covalent crosslinks between domains 
of the protein.
2
  Typically, protein PTM is catalyzed by an associated class of highly 
substrate-specific enzymes.  It can also be produced by proteolytic cleavage or by adding 
a modifying group to one or more amino acid residues.  PTM is ubiquitous in cells since 
almost every mature eukaryotic protein becomes covalently modified during its synthesis, 
cellular targeting, or regulation.
3, 4
 
As key regulators of a variety of protein activities and functions, PTMs are known 
to have an important involvement with mechanisms for controlling intracellular protein 
functions, also possibly related to the regulation of enzymatic activity, modulation of 
molecular processes, stabilization of protein tertiary/quaternary structures, and/or changes 
in the lifetime of the modified protein species.
5
  PTMs alter intrinsic properties of 
proteins such as subcellular localization, turnover, and interactions with other proteins.  
Moreover, the implications of various post-translationally modified proteins and their 
4 
 
substrates have been discovered in many human diseases and ailments, including cancers, 
diabetes and numerous neurological disorders.
4
 
PTMs can be primarily categorized by the types of functional groups attached (or 
detached) covalently to the particular amino acid residues, for instance, the addition of 
small chemical groups like methyl groups known as methylation and removal of 
phosphate groups known as dephosphorylation.  There also exist other types of PTMs, 
such as ubiquitylation, to covalently couple ubiquitin (a 76-residue protein instead of 
chemical groups) to target proteins.
6
  Many types of known PTMs have been discovered 
serendipitously and many more remain yet to be discovered.  With the introduction of 
different biochemical functional groups to specific amino acid residues of proteins, PTMs 
considerably expand nature's repertoire by enhancing the proteome diversity as well as by 
broadening the range of protein structures and functions. 
1.1.2 Methylation 
Protein methylation typically takes place at arginine, lysine, histidine, proline 
residues as well as carboxyl groups.  The transfer of methyl groups to nitrogen or oxygen 
(N- and O-methylation, respectively) to amino acid side chains increases the 
hydrophobicity of the protein and can neutralize a negative amino acid charge when 
bound to carboxylic acids.  Methylation reactions occurring on carboxyl groups can be 
reversible and modulate the activity of the target protein, while those on nitrogen atoms 
at the N-terminus and on side-chains are usually irreversible.  In general, methylation 
bears implications in the regulation of many cellular processes including protein stability, 
5 
 
transcription (gene expression), cellular proliferation, RNA processing and transport, 
translation, signal transduction, DNA repair, apoptosis etc.
7-9
 
1.1.3 Phosphorylation 
Phosphorylation, essentially at serine (Ser), threonine (Thr), and tyrosine (Tyr) 
residues of proteins, is considered to be one of the most important and well-studied 
protein PTMs among the more than 200 known examples.  In eukaryotic cells, large 
proportion of protein phosphorylation takes place on hydroxylated amino acids (O-
phosphorylation) with Ser phosphorylation accounting for ~90%, Thr phosphorylation for 
~10% and Tyr phosphorylation for only ~0.05% of all phosphorylated amino acids.
10
 
Reversible phosphorylation is an essential regulator of cellular functions with 
broad implications in many cellular signaling and regulatory mechanisms.  The repertoire 
of phosphorylation sites in a proteome (phosphoproteome) is dynamic and complex.  
Reversible phosphorylation events are crucially involved in a range of dynamic 
biological regulatory mechanisms that trigger essential cellular signaling processes, 
through which cells modulate protein activity in response to environmental stimuli.  
Therefore, phosphorylation is believed to play a critical role in the regulation of many 
important cellular processes such as controlling the cell cycle (cell division, growth, 
differentiation, apoptosis and metabolism), protein-protein interactions, and signal 
transduction pathways as well.
9, 11
  It is estimated that in eukaryotic cells of higher 
organisms, up to one third of all proteins are phosphorylated at any given time and the 
corresponding protein kinases or phosphatases are estimated to constitute between 2–5% 
of the human genome codes.
12
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1.1.4 Glycosylation 
Protein glycosylation is acknowledged as one of the key and most diverse PTMs 
in eukaryotic cells, with significant effects on cell recognition, protein folding, 
conformation, distribution, stability and activity.  Also known for altered glycosylation is 
its influence on the immune system and implications in several inflammatory diseases, 
cancers, and congenital disorders.
13
  At least 50% of human proteins are glycosylated and 
in some estimation the ratio is up to 70%.
14
  In contrast to the non-enzymatic process 
glycation, glycosylation involves the enzymatic addition and removal of carbohydrate 
residues on proteins.  Two major groups of glycosylation can be defined based on the 
addition of carbohydrates in the form of aspargine-linked (N-linked) or serine/threonine-
linked (O-linked) oligosaccharides.  The pronounced heterogeneity of glycosylation 
manifests itself in the diverse selection of glycan structures attached to protein substrates, 
ranging from simple monosaccharide modifications to highly complex branched 
polysaccharides. 
The physicochemical properties of a recombinant protein can be largely altered 
with the addition of glycans to the polypeptide backbone, including its folding, self-
association, protection from proteolytic degradation, resistance to thermal denaturation, 
solubility and protein sorting within the cell.  It can also alter essential biological 
functions, such as the immunogenicity, signal transduction pathways, specific activity 
and ligand-receptor interactions of the protein.
9
  For example, glycosylation results in a 
variety of structural and functional roles in membrane and secreted proteins. 
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1.1.5 ADP-ribosylation 
The discovery of poly-ADP-ribosylation, initially as an unconventional protein 
PTM, can be traced back to almost 50 years ago, when Chambon and his coworkers first 
described the homopolymer of ADP-ribose (ADPr) units, i.e. poly-ADP-ribose (PAR), 
derived from nicotinamide adenine dinucleotide (NAD
+
) hydrolysis with the 
simultaneous release of nicotinamide.
15
  Ever since its discovery, tremendous efforts have 
been made to develop a comprehensive understanding of ADP-ribosylation.  In the late 
1980s researchers reported the isolation of poly(ADP-ribose) polymerase (PARP; 
subdivided as PARP-1 afterwards), the enzyme dedicated to this PTM activity, ensuing 
the next period of intensive biochemical and structural characterization work.
16
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Figure 1.2 Schematic diagram of mono-ADP-ribosylation and poly-ADP-ribosylation: 
the enzyme-catalyzed, reversible PTM of acceptor protein by a single ADPr group for 
mono-ADP-ribosylation and by PAR polymers for poly-ADP-ribosylation. 
As is shown in Figure 1.2, a typical process of poly-ADP-ribosylation, the 
formation of branched or unbranched chains of PAR units onto protein side chains, can 
be subdivided into three parts: the initiation, the elongation and the branching reaction.  
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The initiation is characterized by the attachment of a single ADPr moiety from NAD
+
 to 
the γ-carboxy group of glutamic acid residues or less likely aspartic acid residues, which 
is also referred to as mono-ADP-ribosylation.  This gives rise to the formation of a labile 
ester bond that is unstable in dilute alkali and neutral hydroxylamine.  The elongation 
step involves the transfer of further PAR moieties to an already attached ADPr unit 
through glycosidic linkages, while the branching reaction usually occurs in an irregular 
manner.
17
  Poly-ADP-ribosylation is a dynamic process, with the half-life of the PAR 
polymer being shorter than 1 min in vivo.
18
  The breakdown of PAR is mediated by poly-
ADP-ribose glycohydrolase (PARG), the only known enzyme that hydrolyses the 
glycosidic bond between ADPr units, and thereby liberates free ADPr.
19
 
In general, the enzymes responsible for mono-ADP-ribosylation are either 
bacterial pathogenic toxins or endogenous cellular ADP-ribosyl-transferases (ARTs).  
The latter include members of three different families of proteins: the well characterized 
arginine-specific ecto-enzymes ARTCs (clostridial-toxin-like ARTs), two sirtuins and, 
more recently, novel members of the ARTD (diphtheria-toxin-like ART) family that have 
been suggested to act as cellular mono-ADP-ribosyl-transferases (mARTs).
20
  
ARTs/PARPs use NAD
+
 as a substrate to add PAR to other proteins or themselves via 
auto-modification. 
ADPr can be hazardous to the cell since it can modify histidine, lysine and 
cysteine residues of proteins by non-enzymatic glycation and leads to inhibition of ATP-
activated K
+
 channels.  Moreover, the net effect of the covalent attachment of negatively 
charged long-chain PAR is thought to be drastically altering the properties as well as 
activities of the protein acceptors through both steric and charge effects, ultimately 
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modulating protein-protein interactions, enzymatic activities or subcellular localization.
21, 
22
  As a result, ADP-ribosylation changes the activities and properties of the target 
proteins typically by interfering with the binding to other macromolecules.  It can also 
possibly create new sites of interactions with different protein modules.
23
  Overall 
speaking, the reversible ADP-ribosylation reaction bears significant implications with 
many physiological processes through regulation of multiple cellular processes covering 
maintenance of genomic stability (through regulation of DNA repair), inter- and intra-
cellular signaling, transcription, gene expression, membrane transport regulation (protein 
localization), necrosis, and programmed cell death (apoptosis), DNA repair pathways, 
apoptosis and cell cycle control.
22, 24, 25
  It occurs in almost all nuleated cells of mammals, 
plants and lower eukaryotes, but is absent in yeast.
15
  Typically, PARP enzymes have 
well-established roles as potent bacterial toxins and metabolic regulators, carrying 
relevancy to many diseases including inflammatory diseases, diabetes and cancers.
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1.2 Mass Spectrometry in the Analysis of PTMs 
1.2.1 General Remarks 
The concept of “proteome” (the PROTEin complement of a genOME) was first 
proposed in 1996 by Andrej Shevchenko et al.
27
  In the post-genomic era, proteomics, the 
analysis of a proteome i.e. the large-scale study of proteins particularly their structures 
and functions is gaining importance, as the PTM properties of proteins cannot be 
determined from the DNA sequence alone using the mature polymerase chain reaction 
(PCR) techniques.  Numerous routine or specialized approaches have been developed to 
analyze protein PTMs qualitatively or quantitatively.  The core principles of many 
11 
 
detection methods are elegantly simple: to discriminate the difference of an experimental 
variant corresponding to the introduction of a specific PTM on the target protein/peptide.  
By detecting the characteristic mass change (increment or deficit) as a result of the 
modification, mass spectrometry (MS) offers an attractively straightforward way of the 
identification and characterization for a multiple of protein PTMs.  The increasingly 
widespread use of MS in the analysis of PTM is due in large part to its ability to solve 
structural problems not easily handled by conventional methods. 
MS techniques, especially electrospray ionization mass spectrometry (ESI-MS) 
and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), are to 
date the most powerful and indispensable tool to achieve global proteomic profiling.  In a 
narrower sense, MS-based proteomics encompasses techniques for protein quantification 
and determination of protein primary structure, including PTMs as well as protein-protein 
interactions.  The elucidation of protein PTMs remains an important branch of MS 
applications, including the identification of post-translationally modified proteins, the 
determination of PTM sites on proteins/peptides and site-specific quantitation of protein 
PTMs as well. 
12 
 
1.2.2 Instrumentation of Mass Spectrometers 
 
Figure 1.3 Simplified schematic for the typical composition of a mass spectrometer. 
Simplistically, a mass spectrometer is composed of three major parts: an ion 
source, a mass analyzer that separates analyte ions by mass-to-charge ratio (m/z), and a 
detector that registers the number of ions at each m/z value.  Details of the ion source and 
mass analyzer tend to define the type of instrument and the functionalities of MS systems. 
1.2.3 Soft Ionization Techniques for Protein and Peptide Analysis 
1.2.3.1 Electrospray Ionization 
As one of the two “soft” ionization techniques enabling minimal fragmentation 
during the ionization process, electrospray ionization (ESI) was initially reported in 1989, 
allowing for sensitive detection of large, non-volatile and thermally labile molecules by 
MS.
28, 29
  ESI generates a continuous supply of ions from the liquid phase, where a 
charged analyte solution is emitted from a nozzle, needle, or capillary in the presence of a 
strong electric field.  One feature of ESI is that the acidic conditions used to generate 
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positively charged droplets tend to protonate all available basic sites in the analytes, 
leading to the generation of multiply protonated species. 
1.2.3.2 Matrix-assisted Laser Desorption/Ionization 
Matrix-assisted laser desorption/ionization (MALDI) is another soft ionization 
technique that provides sensitive analysis for a great diversity of analytes, in particular 
biopolymers such as proteins and peptides.  Ever since its first inception in the late 1980s 
by Karas et al. and Tanaka et al. as a method of forming intact gas-phase ions from large 
and labile molecules, MALDI-MS has developed into one of the most essential analytical 
techniques in life science with widespread applications in the characterization of peptides, 
proteins, as well as organic polymers.
30
  The substantial contribution by ESI and MALDI 
to the analysis of biological macromolecules was acknowledged as a shared Nobel Prize 
in Chemistry in 2002. 
By definition, the term “matrix” refers to small, laser absorbing organic molecules 
that are used in high molar excess over the analyte molecules and co-crystallize with 
them on the MALDI target plate to form a homogeneous layer of small crystals.  This co- 
crystallization leads to the co-desorption (evaporation into the gas phase upon irradiation 
with a pulsed laser) of intact non-volatile, labile molecules with the matrix and 
concurrently, the ionization of sample molecules.  The function of the matrix is to absorb 
and accumulate the energy of the laser irradiation and, thus, minimize possible sample 
damage and fragmentation.  The entire desorption/ionization process represents the core 
of the MALDI principle. 
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1.2.3.3 Comparison between MALDI and ESI 
Both ESI and MALDI have their advantages and disadvantages and the choice of 
instrument depends on the sample and level of accuracy and information that is required.  
ESI is often linked to HPLC instrumentation, while MALDI-TOF is more adapted to 
high-throughput approaches and therefore more suitable to large-scale proteomics.
31
  
Since the advent of MS-oriented proteomic studies, ESI has often been employed in 
peptide sequencing after HPLC separation, while MALDI has been used to mass 
fingerprint mixtures of peptides.  This division of effort is derived from the fact that ESI 
can be easily coupled on-line to front-end fractionation such as HPLC since both 
techniques are liquid-based, and MALDI can readily be implemented for the analysis of 
peptide mixtures without resorting to separation.  As a result of the vacuum conditions 
required for MALDI ionization process to take place, its online coupling with liquid-
phase separation techniques remains less straightforward.
32-34
  Separation of analytes 
prior to MALDI, however, reduces ion suppression and leads to higher signal-to-noise 
ratios (S/N) and greater sensitivity.  With respect to robustness, higher tolerance of 
contaminations such as salt additives, faster speed, higher accessible m/z range and 
simple interpretation of the acquired spectra due to the exclusive production of 
predominantly singly-charged ions, MALDI is favored over ESI. 
1.2.3.4 MALDI-TOF 
A time-of-flight (TOF) mass analyzer separates accelerated ions based on the 
differences between their velocities.  Recent years has witnessed the tremendous 
commercial renaissance of the TOF mass analyzers, to which MALDI sources are 
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generally interfaced due to the fact that both techniques are pulse-based.  Amenable to 
the analysis of high m/z ranges, MALDI-TOF MS is a powerful tool for analyzing 
peptides and proteins by linear or reflectron mode (further reading available in Appendix 
A).  It has successfully been implemented in the accurate determination of 
proteins/peptide masses with high sensitivity (low fmol range) and good mass accuracy 
(low ppm range), providing attractive analytical features for the unbiased analysis of 
protein PTMs.
35
 
1.2.4 Tandem Mass Spectrometry 
Currently more than 300 different types of known and new PTMs are regularly 
discovered.  Most PTMs can be detected by monitoring the corresponding mass shifts, 
attributed to the unambiguous information provided by either MALDI-MS or ESI-MS 
concerning a mass increment or a mass deficit compared to the original unmodified 
protein (Figure 1.4).  Nevertheless, another critical issue and also major challenge for 
PTM analysis remains to be the localization of PTM sites.  To date, the most frequently 
used method for the full identification and in-depth characterization of protein PTM 
patterns is tandem mass spectrometry (MS/MS) combined with protein sequence database 
like Mascot.
36-38
  Large-scale, quantitative analysis of proteins by MS/MS has been 
proved to reveal novel patterns and functions of PTMs in cellular signaling networks and 
biomolecular structures. 
MS-based protein analysis can be performed using sequence-specific peptide 
fragmentation or peptide mass fingerprinting (PMF), also known as peptide mass 
mapping.  The characterization of unknown proteins and the determination of PTM 
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locations by MS/MS are generally involved with a two-step process of sequencing 
peptides obtained from PMF and database search.  As is illustrated by Figure 1.4, after 
the molecular mass determination of the peptide through MS analysis, the peptide peak of 
interest is isolated and subject to further fragmentation by collision induced dissociation 
(CID).
37
  The resulting peptide fragments are subsequently directed to a second mass 
analyzer.  Fragmentation of the peptide amide bond produces a set of fragment ions that 
generate a ladder-like readout of the sequence in the MS/MS profile.  The presence of a 
PTM alters the mass of the modified amino acid residue together with the peptide, and 
the information concerning the mass and identity of the PTM as well as the position of 
the modified amino acid residue can in turn be revealed by MS/MS. 
 
Figure 1.4 Schematic representation of peptide analysis by MS for detecting PTMs and 
peptide sequencing by MS/MS for mapping PTMs. 
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1.3 Separation Techniques for PTM Analysis and Protein 
Sample Preparation 
The fact that proteins carry many modifications increases the molecular 
heterogeneity and diversity of gene products.  Although MS-based proteomics research 
has enjoyed tremendous success, it is still confronted with significant challenges for such 
a complicated large-scale proteome research.  Firstly, it is conceivable that for complex 
biological samples, particularly for protein mixtures that contain thousands of different 
protein species with several orders of magnitude variation in abundance, the extent of 
pre-fractionation correlates with the number of detectable proteins and their PTMs.  
Secondly, it is also well known that proteins are dynamic with a large range of expression 
levels (protein concentrations), which means a large proportion of proteins exist in 
extremely low abundance and therefore are likely to suffer from MS signal suppression 
by the more abundant ones, such as the biologically significant phosphoproteins with low 
stoichiometry.
39
  The successful detection and characterization of these low-abundance 
species, as a consequence, rely greatly on sample pretreatment such as fractionation, 
enrichment and derivatization.  Last but not least, purification steps prior to MS analysis 
contribute to the removal of contaminants that would interfere with MS detection.  In the 
domain of proteomics, purification or pre-fractionation techniques encompass majorly 
chromatographic and electrophoretic methods, as well as affinity capture/enrichment and 
immuno-precipitation (IP), all of which can be readily interfaced to MS in an online or 
offline fashion to fulfill the task of global PTM profiling.
40, 41
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1.3.1 Gel Electrophoresis 
1.3.1.1 One-Dimensional Electrophoresis 
In one-dimensional gel electrophoresis (1D-GE), the separation of the analytes in 
a single dimension is achieved by on-gel electrophoretic migration induced by a high 
potential difference, based on their diversified molecular weight (MW).  Sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is highly applicable to the 
separation of multifarious components in a protein mixture, and is often the final stage of 
purification of individual proteins.  The main advantages of SDS-PAGE are simplicity, 
good reproducibility, and wide mass range.  However, it is typically not suitable for the 
differentiation between highly related protein species.  Only PTM that generates a 
considerable MW difference can be detected on a 1-D gel as an observable band shift. 
1.3.1.2 Two-Dimensional Electrophoresis 
Separations in single dimension are inadequate to effectively resolve complex 
protein mixtures.  With the advent of two-dimensional electrophoresis (2-DE) technique, 
considerably complex protein mixtures are able to be separated, resulting in enormous 
improvements on the identification and characterization of different protein species and 
isoforms.  The 2-DE separation is based on two orthogonal characters, isoelectric point 
(pI; the pH at which an analyte display a net neutral charge) and MW, and provides 
exceptionally high resolution is the combination of isoelectric focusing (IEF; first 
dimension) and SDS-PAGE (second dimension).  The separated proteins form spots on 
the plate, which may be cut out for further analysis.  Despite its labor-intensive and time-
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consuming operation, 2-DE are very powerful and are capable of resolving complicated 
protein mixtures, regarded as one of the most important and broadly applied techniques in 
the field of proteomics. 
Noteworthy, 2-DE separation of proteins also allows monitoring and investigation 
of post-translationally modified species due to corresponding shifts in pI values and/or 
MW upon covalent modifications of proteins.  It often has sufficient resolution to 
separate the modification states of a protein directly.
42
  For instance, by introducing a 
negatively charged phosphate, phosphorylation changes the overall protein charge and is 
often indicated by a horizontal trail of protein spots on the 2-D gel.
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However, as a gel-based method, 2-DE suffers from a series of limitations, 
including limited sample capacity, low detection sensitivity, difficulty to separate 
transmembrane proteins and limited throughput.  In addition, the detection of low-
abundance proteins can be hampered by proteins with similar sizes and charges or by 
expression levels below the current detection limits of the analytical techniques used.  
Other drawbacks with regard to gel-to-gel reproducibility have also to be addressed. 
1.3.2 Chromatography 
As an alternative to gel-based methods, chromatographic techniques provide both 
analytical and preparative applications in the field of proteomics.  In many cases, proteins 
are usually converted into peptides by treatment with sequence-specific proteases or by 
chemical cleavage prior to chromatographic separations, since peptides are more 
amenable to MS and MS/MS analysis than intact proteins.  Conventional liquid 
chromatographic (LC) methods have been established for the separation of proteins and 
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peptides based on their molecular mass, charge (e.g. strong cation exchange [SCE] 
chromatography) or hydrophobicity (e.g. reversed-phase chromatography [RPC]).
43
  
Reversed-phase high performance liquid chromatography (RP-HPLC) has been 
extensively used for sample preparation and fractionation of proteins and peptides with 
excellent recovery and good resolution.  However, it faces problems with the analysis of 
very hydrophobic proteins and hydrophilic peptides, and it may not be easy to achieve 
high-resolution LC separations of highly similar protein species, and hence this 
technology is classically coupled with MS for the identification and characterization of 
PTMs.
44
 One specific analytical approach termed “MudPIT” (multidimensional peptide 
identification technology), is typically involved with the combination of two stages of 
chromatographic separation (SCE and RPC) followed by MS analysis.
45
  Due to higher 
resolving power, MudPIT may show greater potential in PTM studies. 
Affinity protein enrichment, as a unique branch of chromatography, also receives 
wide-range applications in the study of PTMs, and is well adapted to MS analysis for 
purification instead of pre-fractionation purpose.  A good exemplification is 
phosphopeptide enrichment, which is prevalently achieved by metal oxide affinity 
chromatography (MOAC) or immobilized metal ion affinity chromatography (IMAC) 
with strong binding affinity for phosphorylated amino acid residues.  Notably, the 
phosphoproteome sequence coverage can be enhanced by the combination of the methods, 
which is referred to an approach named SIMAC (Sequential elution from IMAC).
46
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1.3.3 MS-Based Proteomics Workflow 
The most widely accepted approach in proteomics based on MS characterization 
is usually referred to as “bottom up” strategy.  Typically, Figure 1.5 shows a general 
workflow of MS-based bottom-up proteomics, incorporating protein fractionation by gel-
based methods (1-GE, 2-DE), LC-based methods (RPLC, SEC, IEC or MudPIT) or 
protein affinity enrichment for any particular analyte of interest, followed by proteolytic 
digestion, analysis of the resulting peptide mixture (after peptide separation or sample 
clean-up if necessary) using various MS approaches and finally, database search.
47, 48
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Figure 1.5 Flowchart depicting the generic bottom-up proteomics workflow.  Gel-based, 
LC-based or affinity-based separation of protein mixtures is utilized in combination with 
MS or MS/MS analysis. 
Nonetheless, the low protein sequence coverage often obtained using the bottom-
up approach hinders the comprehensive characterization of protein PTMs.
48
  
Alternatively, “top down” approaches have been described.  Top-down proteomic 
analysis is avoids any enzymatic digestion, instead intact proteins are subject to pre-
fractionation and MS fragmentation.  This is especially effective in unraveling complex 
PTM patterns.
49, 50
  Effective top-down analysis, however, is still confined to 
requirements for extremely high mass resolution, mass accuracy and the ability of 
efficiently fragmenting large ions. 
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1.4 Capillary Electrophoresis in PTM Analysis and 
Protein Sample Preparation 
1.4.1 General Remarks 
Nowadays, as a separation tool that combines several features of column 
chromatography and electrophoresis, and one of the most important analytical techniques 
comparable to 2-DE and HPLC, capillary electrophoresis (CE) has become a robust and 
versatile analytical implement for a wide variety of analytes with broad ranges of 
applications.  Advantages of CE methods over traditional chromatographic methods 
include its resolving power, low sample quantity and minimal chemical consumption as 
well, while the major limitation is its low sensitivity.  Easy automation of the analytical 
procedures as well as simplicity of the instrumentation also gains vast popularity for CE 
in regular analytical applications, which are advantageous over the tedious 1-GE or 2-DE 
procedures.  Furthermore, CE exhibits outstanding analytical performance particularly for 
proteins and peptides by providing good resolution, high efficiency, minute sample 
consumption and often complementary selectivity to conventional chromatographic 
separations.
51
  Although the incorporation of CE separation into the proteomics workflow 
is less reported, its importance in bioanalysis increases with the growing effort to 
understand the composition and function of proteins in living bodies including the 
significant PTM properties of proteins.
52, 53
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1.4.2 Instrumentation and Principles of Capillary Zone 
Electrophoresis 
Capillary zone electrophoresis (CZE) is the main CE separation mode utilized for 
the analysis of biomolecules and has been widely applied in peptide mapping and for the 
evaluation of the charge heterogeneity of proteins.
54
  In CZE it is desirable to be able to 
tune the composition of the background electrolyte (BGE) so that separations can be 
optimized.  Moreover, the possibility of using volatile BGE provides a high compatibility 
of CZE with MS.  Proteins and most peptides are ionogenic substances which also bear 
other functionalities such as hydrogen-bonding regions, hydrophobic patches and 
biospecific interaction sites that may interact to different extents with the components of 
the BGE.  Depending on the chemical nature of the proteins/peptides and the ionic 
species in solution, such interactions can lead to significant variations in the 
electrophoretic mobility of these analytes that can greatly affect their selective separation 
by CZE.
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One key feature of CE is the simplicity of the instrumentation as is depicted in 
Figure 1.6.  A typical CE set-up consists of a capillary, two buffer reservoirs, a sample 
reservoir, a high voltage supply, pressure system for the rinsing of the capillary and a UV 
detector.  An electrical field of up to 30 kV may be applied through electrodes immersed 
in the electrolyte solution in the two buffer reservoirs.  The capillary is filled with buffer 
and an injection is carried out by moving the capillary from the buffer reservoir of the 
inlet side to the sample reservoir.  Frequently-used modes of CE sample injection include 
hydrodynamic injection which is driven by pressure, and electrokinetic injection which is 
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driven by voltage.  After injection, the capillary is positioned back to the buffer reservoir 
followed by voltage application, and the separation takes place.  The CE separation of 
charged compounds is dependent on the differential migration of analytes in an applied 
electric field.   
 
Figure 1.6 Schematic of typical CE instrumentation.  The enlarged section shows the 
directions of the electrophoretic mobility and electroosmotic flow. 
 Electroosmotic flow (EOF), defined as a bulk flow of buffer through the CE 
system in the presence of an electric field, is a critical factor in many CE studies.  The 
generation of EOF pheonomenon is unique for CE systems, and is a direct result of the 
surface charges on the interior capillary wall.  That is, the ionization of the surface silanol 
groups (-SiOH) in a fused silica capillary occurs under aqueous conditions above pH 4, 
resulting in net negative charges (-SiO
-
).  As a consequence, the electric double-layer 
forms at the silica-buffer interface in order to maintain electroneutrality, i.e. the buffer 
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cations adsorb onto the anionic wall via electrostatic interactions and form a rigid or 
immobile Stern layer, while the remaining buffer cations form a loose diffuse-layer 
(Figure 1.7).  When an electric filed is applied through the capillary filled with 
electrolytes, the cations in the diffuse layer will start to migrate towards the cathodic end 
of the capillary.  Since they are solvated in the buffer, their moment drags the bulk 
solution with it.  The characteristic of the EOF is the flat flow profile, in contrast to the 
pressure driven parabolic (laminar) flow usually obtained in chromatographic analysis 
(Figure 1.8).  This is because its driving force is evenly distributed along the capillary, 
which means that no pressure drops are encountered and the flow velocity is uniform 
across the capillary.  Zone broadening can be minimized with such a flat profile, 
contributing to high separation efficiencies. 
 
Figure 1.7 Schematic representation of the generation of EOF.  Ψx is the potential at the 
distance x from the surface, Ψ0 is the surface potential, Ψδ is the stern layer potential and 
ζ is the zeta potential. 
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Figure 1.8 Schematics showing the (A) EOF flat flow profile and (B) laminar flow 
profile. 
Apparent mobility (µa), the mobility of an analyte in the presence of EOF, is 
expressed as the vectorial combination of electrophoretic mobility (µe) and 
electroosmotic mobility (µeof). 
 
 
   
 
  
   
  Equation 1.1 
where µa and µeof can be directly calculated from the migration time of the 
analytes and the neutral EOF marker, respectively.  A negative value of µeof is indicative 
of the anodic direction of the EOF, whereas a positive value of µeof indicates that EOF is 
directed towards the cathode.  Notable is that µeof is independent of the electric field.  
Given a buffer of specific pH, the electrophoretic mobility of a charged species toward 
the electrode of opposite charge can be approximated from the Debye–Hückel–Henry 
theory, 
 
 
  
 
    
  Equation 1.2 
where q is the net charge of the ion, η is the buffer viscosity, and r is the ionic 
radius of the analyte.  The charge q can be determined by the buffer pH, whereas the 
radius r is affected by many factors including counter-ion effects, non-spherical shape or 
other non-ideal behaviors of molecules.  The size of an analyte is often approximated as 
B
  B 
A
  B 
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the mass of the molecule, and thus the analytes are separated based on their “charge-to-
size ratio”, or in some circumstances “charge-to-mass ratio”.  Naturally, an ion with 
higher charge and smaller size will have greater mobility, whereas lower charge and 
larger size means lower mobility.  Deduced from this equation, µe is also proportional to 
the charge-to-mass ratio of the analyte: 
 
 
 
      
    
  Equation 1.3 
Since different ions have different charge-to-size ratios, separation can take place 
due to differentiated electrophoretic mobility.  Generally speaking, at a given EOF, 
analytes with smaller sizes and higher net charges tend to migrate faster toward the 
electrode of opposite charge in a CE run, as is illustrated in Figure 1.9. 
 
Figure 1.9 Schematic representation of in-capillary ion migration behavior in an 
uncoated capillary. 
1.4.3 PTM Analysis by CE Separation 
To be specific, many protein PTMs result in a change of net charge of the 
modified protein and thus also of its electrophoretic mobility.  With outstanding 
separation efficiencies, CE is envisioned to have great potential for the separation of a 
variety of protein PTMs in a single run.  An important feature of CE separation of 
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peptides is that their electrophoretic migration properties as a function of pH can be 
predicted from theoretical models, because of the amino acid residues with variant 
ionizable side chains that alter the charge distribution upon environmental pH change.
42
  
The nature of most conventional PTMs remains the attachment or detachment of certain 
chemical/biological groups, which bring about both mass change and charge variation.  
Going back to Equation 1.3, which states the effect of both charge and MW on the CE 
electromigration of analytes, it is reasonable to come up with the idea of separation-based 
identification of PTMs by modeling the electrophoretic mobility difference between the 
modified form and the unmodified counterpart.  It has been reported that a number of 
peptides contain PTMs which can be readily detected based upon their relative 
electrophoretic mobility in CE.
56
  Furthermore, correctly accounting for the total charge 
in the post-translationally modified analytes allows for the correlation of the expected 
mobility with the measured mobility. 
A critical limitation and also challenging task of CE in the analysis of 
biomolecules that has to be addressed, however, is the protein adsorption issue.  
Specifically, positively charged domains of the analyzed proteins preferentially adsorb to 
negatively charged capillary interior surface and vice versa.  Such protein-wall 
interactions can result in peak tailing, band broadening, poor separation efficiencies, low 
sample recoveries, as well as non-reproducible migration time.  To inhibit or circumvent 
these effects, several attempts have been made including high pH, high ionic strength and 
the incorporation of zwitterionic additives in the BGE.  The most popular approach to 
minimize sample-wall interactions remains the manipulation of surface charge of the 
capillary wall, simply achieved by different kinds of capillary coating techniques, either 
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dynamic or static.
57
  Even though dynamic coatings are easy to apply and can be 
produced simply by flushing the capillary with solutions of the adsorptive coating agents, 
they do not eliminate EOF and sample adsorptions completely.  On the other hand, static 
coatings, the permanent and covalent attachment of the coating materials to the capillary 
inner surface, are generally more difficult to produce and regenerate but more effective at 
eliminating protein adsorption, and more stable compared to dynamic coatings.
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1.4.4 CE Sample Preparation Coupling to MALDI-MS 
Owing to rapid analysis, high resolving power and low sample consumption, CE 
is gaining growing interest in the field of proteomics.  Nevertheless, to ensure unbiased 
characterization, CE-MS coupling is indispensable as unambiguous mass information can 
be obtained via high-resolution MS techniques, which is essentially crucial to the 
confident determination of PTMs in particular.  As the sample capacity and concentration 
sensitivity in CE is low, the high sensitivity of MS makes it possible to detect low 
abundant species.  Furthermore, the capability of small-volume sample handling by CE is 
favorable to the downsized analysis.  Besides, despite the exceptional analyzing power 
and good capacity for sample complexity of MS, to gain the best sensitivity and 
selectivity by reducing the risk of ion suppression, a separation stage prior to the MS 
analysis is usually fundamental.  The coupling of a rapid and efficient CE separation 
technique with highly sensitive MS detection can therefore offer powerful analytical 
performance and further extend the utility of both techniques.  Nowadays, CE-MS has 
received wide-range applications for many analytical purposes and is in particular 
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suitable the analysis of highly polar ionogenic and charged substances which could be 
difficult to handle using LC-MS methodology. 
Another exciting aspect of CE sample preparation in addition to separation prior 
to MS remains the development of in-capillary sample pretreatment procedures.  
Miniaturization is a common trend in contemporary analytical developments, because of 
the need to perform large numbers of analyses on biological materials of interest. This 
can be fulfilled by CE due to its ability of small-sample-volume handling. The small 
dimension of the capillary as well as the ability of small-volume sample handling (at sub-
µL level) makes it an attractive technique to develop CE-based miniaturized platform for 
downsizing purpose. 
Among a diversity of MS techniques, ESI-MS can be most conveniently 
interfaced to CE since both techniques are flow-based.  However, compared to ESI, 
MALDI exhibits higher tolerance against contaminants, CE buffer salts and 
additives/coatings used for prevention of sample adsorption onto the capillary wall.  To 
combine CE with MALDI-MS offers an opportunity to separate and identify analytes 
with potential for automation and high throughput.  CE provides low sample 
consumption, high separation efficiency and strong resolving power while the soft 
ionization with MALDI can manage large peptides/proteins with desirable mass accuracy, 
resolution, sensitivity together with high throughput capability for large-scale analysis.  
However, since the MALDI ionization process is typically undertaken in a vacuum inside 
the mass spectrometer, and the electrophoretic separation is hard to maintain during the 
fractionation, the practical online interfacing of MALDI-MS with CE is considerably 
hampered.  Additionally, the offline CE-MALDI-MS coupling is not straightforward due 
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to the minute sample volume in CE as low as a few nanoliters.
34
  In spite of these 
technical impediments, either offline or online mode of CE-MALDI-MS hyphenation has 
been achieved via different experimental designs. 
1.5 Thesis Overview 
The overall aim of this thesis was to study protein PTMs especially ADP-
ribosylation, and miniaturized peptide derivatization especially methyl esterification by 
taking advantage of CE separation efficiency, small-volume sample handling and 
instrumentation, which reflects two major applications of CE, i.e. separation and sample 
pretreatment.  In combination with CE, MALDI-MS also provides outstanding analytical 
performance with regards to biomolecules such as peptides and proteins, and was used in 
both experimental approaches with the purpose of identifying specific modifications on 
proteins or peptides.  In short, this work can be divided into two body chapters: 
separation-based analysis of protein ADP-ribosylation, and in-capillary derivatization for 
miniaturized methyl esterification of phosphopeptides. 
As an excellent complement to traditional bioanalytical techniques such as HPLC, 
1-GE and 2-DE, CE is an extremely powerful separation tool with exceptional separation 
efficiency and short analysis time.  Therefore, it was considered a promising alternative 
to the traditional analytical methodologies for ADP-ribosylation.  In chapter 2, qualitative 
CE analysis of ADP-ribosylation was performed, with special focus on the catalytic 
domain of ARTD-10, an enzyme responsible for plausible mono-ADP-ribosylation.  The 
purpose of this work was to develop an optimized CE separation mode for ARTD-10 and 
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its potential mono-ADP-ribosylated counterpart, in an attempt to elucidate the 
biochemical activity of ARTD-10. 
One growing area of interest in CE is the development of strategies for integrating 
multiple sample pretreatment procedures such as desalting, preconcentration, 
derivatization and extraction, which are often time-consuming and labor-intensive in the 
conventional approach.
59, 60
  As a consequence, it is also of interest to take advantage of 
the utility of CE’s small-volume sample handling (at sub-µL level) to fulfill miniaturized 
sample preparation, such as in-capillary derivatization, in conjugation with specific 
sample pretreatment if applicable.  In chapter 3, preliminary efforts towards in-capillary 
methyl esterification of phosphorylated peptides for MALDI-MS analysis along with on-
capillary-tip sample recovery after removal of unfavorable organic solvents were 
presented, in an attempt to develop subsequent in-capillary recapture and enrichment of 
target molecules by means of either dynamic pH junction or solid phase extraction using 
immobilized magnetic beads. 
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Chapter 2. Analysis of ADP-Ribosylation by Capillary 
Electrophoresis 
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2.1 Introduction 
Compared to protein poly-ADP-ribosylation, mono-ADP-ribosylation remains 
little explored and recent studies indicate that they have potentially very important roles 
to play in a number of complex biological processes like metabolism, cellular signaling, 
membrane trafficking, gene regulation, cell proliferation and immunity.
1-3
  As the 
enzymes responsible for mono-ADP-ribosylation reactions, mARTs have gained great 
research interest recently.  In the past decade, genomic techniques led to the identification 
of 18 recognized PARP/ARTD sequences in the human genome, all of which contain a 
conserved catalytic domain and additional specificity domains.
4
  A recent structure-based 
classification of PARP family members divide them into three groups based on the 
differentiation of their catalytic domains: (1) ARTDs 1–5, which are bona fide 
polymerases containing a conserved glutamate (Glu 988 in PARP-1) that defines the 
PARP catalytic activity; (2) ARTDs 6–8, 10–12, and 14–16, which are confirmed or 
putative mARTs; and (3) ARTDs 9 and 13, which lack key NAD
+
-binding residues and 
the conserved catalytic glutamate residue, are thought to be inactive.
5, 6
 
Despite the general acceptance of such activity-based categorization, the 
clarification of the functional aspects of ARTD-10, a nuclear and cytosolic protein with 
1025 residues and a C-terminal consensus PARP domain (Figure 2.1), is not that 
straightforward.  ARTD-10 (PARP-10) was first reported by Yu et al. to present 
polymerase activity as a new member of the PARP family in 2005, in consideration of its 
structural homology to RNA recognition motifs and to most of PARP enzymes.
1
  In their 
findings, ARTD-10 was able to poly(ADP-ribosyl)ate itself and core histones.
7
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Nevertheless, the presence of a conserved glutamate residue in the active center was still 
disputable at that time.  In the meantime, another line of researchers also further 
confirmed that the catalytic domain of ARTD-10 possesses active polymerase activity.  
Firstly, it was revealed by sequence comparison that a PARP catalytic domain located in 
the C-terminal portion of ARTD-10 conserved the most important secondary structures as 
well as some of the critical residues for NAD
+
-binding.  Secondly, the ADP-ribosylation 
reaction was blocked with the inclusion of a PARP-specific inhibitor 3-aminobenzamide 
(3-AB), an indication that the activity of ARTD-10 is analogous to PARP1-catalyzed 
poly-ADP-ribosylation.
8
  In 2008, based on the detailed evaluation of the enzymatic 
properties of ARTD-10, Luscher and coworkers demonstrated that ARTD-10 actually 
exhibit transferase activity rather than polymerase activity due to the absence of an 
otherwise conserved catalytic glutamate in the active site.
6
  In this work, the authors 
suggested that ARTD-10 catalyzes ADP-ribosylation onto glutamic acid or aspartic acid 
residues of target proteins, involving a mechanism called substrate-assisted catalysis.  
The molecular basis for such substrate-assisted catalysis, which limits the activity of 
ARTD-10 to mono-ADP-ribosylation, was proposed on the basis of sequence alignments, 
biochemical characterization and molecular modeling.  Intriguingly, PARP-10 is 
currently accepted as mART to catalyze mono- instead of poly-ADP-ribosylation 
reactions.  ARTD-10 does not seem to be capable of modifying cysteine or arginine 
residues but rather is suggested to mono-ADP-ribosylate glutamates.
2
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Figure 2.1 Protein sequence of full length ARTD-10 (PARP-10).  RNA recognition motif 
(RRM) (in red), a Gly-rich region (in green), a Glu-rich region (in bluegreen), nuclear 
export sequences (NES) (in yellow), and ubiquitin-interaction motifs (UIM) (in bluegreen) 
are shown.  The PARP domain is shaded in gray. 
Recent years have witnessed a tremendous influx of novel techniques that led to a 
breathtaking expansion of the ADP-ribosylation research scope.  Traditional analytical 
approaches in separation, identification and characterization for ADP-ribosylated species 
include RP-HPLC coupled with MALDI-MS and ESI-MS, SDS-PAGE, radiolabeling 
NAD
+
.
9-11
  For SDS-PAGE, only PAR could generate detectable band shift.  In previous 
studies on ARTD-10 purified from mammalian cells, its transferase instead of 
polymerase activity was verified due to the absence of size shift in PAGE gels that 
derives from the addition of PAR polymers in contrast to PARP-1.
2
  However, this poses 
a potential drawback for the GE analysis of mono-ADP-ribosylation due to the fact that 
the addition of a single ADPr group onto a large protein substrate does not give rise to 
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observable band shift on the gel.  Nonetheless, it has been reported that radiolabeled 
target proteins can be detected by SDS-PAGE autoradiography using radioactively 
labeled [
32
P]-NAD
+
 as a substrate.
12
  Radiolabeling technique receives tremendous 
success in the detection of ADPr moiety and has been using extensively in all kinds of 
relevant studies.
13
  However, a major issue exists for the potential hazard of radiolabeling, 
which is undesirable for routine analysis.  Last but not least, the idea of generating 
antibodies that recognize mono-ADP-ribosylated targets might sound straightforward, but 
the development of this approach is still in its infancy and suffers from low specificity, 
namely the trend of showing cross reactivity with other poly-ADP-ribosylated species.
12
 
MS/MS (or MS sequencing) is also a well-established method for the analysis of 
ADP-ribosylation particularly the identification of modification sites.
14
  Specific ADP-
ribosylated amino acid residues can be identified given that the purified ADP-ribosylated 
protein is subject to protease digestion.  The resulting peptides are fractionated by HPLC 
and subsequently identified by MS sequencing.  The use of LC coupled to MS/MS to 
identify and characterize sites of ADP-ribosylation has also been reported.
15
  However, 
due to the complexity of the modification and the fragmentation pattern in MS/MS CID 
experiments, the identification of ADP-ribosylation sites in complex mixtures is difficult.  
That is, the (ester) linkage between the ADPr and the acceptor residue is labile under MS 
condition, and ADPr itself is prone to fragmentation due to the labile pyrophosphate and 
adenine moieties, and the presence of a PTM on a peptide can redirect fragmentation 
patterns to make the sequence assignment difficult.
15, 16
  To facilitate the MS analysis and 
detection of ADP-ribosylation, two new techniques have been developed recently.  In one 
approach, the fragmentation of ADPr-containing tryptic peptides generates characteristic 
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breakdown products of ADPr or ADP-ribosylated species that can be used to trace the 
ADP-ribosylated peptides.
15, 17
  In a second approach, tryptic fragments containing ADPr 
moieties were specifically enriched using a TiO2 affinity matrix before MS analysis.  
Here we describe a two-step strategy, in the first step enriching and identifying 
potentially ADP-ribosylated proteins and in the second step identifying the sites of 
modification by a combination of LC-MS and LC-MS/MS experiments.
18
 
As an attractive alternative to the above-described techniques, capillary 
electrophoresis (CE) can be utilized in the analysis of ADP-ribosylation due to its 
exceptionally high separation efficiency.  Easy automation and simple instrumentation 
circumvent the labor-intensive work required for SDS-PAGE.  Furthermore, owing to 
effective dissipation of heat as a result of high surface-area-to-volume ratio, much higher 
separation voltages can be used in CE, in contrast to 1-GE and 2-DE.  “Clean” buffer 
environment used in CE is also advantageous over the radiolabelling approach.  
Compared to conventional chromatographic methods, the separation efficiency of CE can 
be extremely high for large biomolecules such as proteins, as longitudinal diffusion 
ideally the predominant contributor to peak broadening in CE is relatively low.  In a 
recent finding, a conjecture was proposed that human ARTD-10 (hARTD-10) appeared 
to exhibit auto-modification activity and also seemed to modify CK2-alpha, supported by 
the observations of sample band shifts in GE for both cases (Appendix E).  Moreover, 
there was possibility that such auto-modification might in turn affect its catalytic activity.  
To shed light on this plausible modification in terms of biological function, the 
identification of targets and modification sites is also necessitated.  These as a whole led 
to a strong research interest and also contributed to our collaboration with Dr. Brian 
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Shilton (the Department of Biochemistry, Western University) in joint efforts to explore 
an alternative analytical tool for better separation and characterization of the supposed 
mono-ADP-ribosylated ARTD-10 and its unmodified counterpart.  In addition to 
separation efficiency, CE provides an unrivalled selectivity with regards to the separation 
of complex mixtures of closely related proteins, differing only slightly in their primary 
sequence, in their PTMs or merely in their conformational state.
19
  The purpose of this 
study is thus to take advantage of the outstanding separation power and selectivity of CE 
to develop an optimized CE separation mode for ARTD-10 and its potential mono-ADP-
ribosylated counterpart, in an attempt to elucidate the biochemical activity of ARTD-10. 
2.2 Experimental Section 
2.2.1 Apparatus 
 All CE-related experiments were performed on an Agilent 3D-CE (Palo Alto, CA, 
USA) instrument equipped with a direct UV-Vis absorbance detector at 254 nm for 
mesityl oxide (as neutral EOF marker) and 200 or 214 nm for peptides and proteins.  
Untreated fused silica capillaries were purchased from Polymicro Technologies (Phoenix, 
AZ, USA) with an inner diameter (i.d.) as 50 µm and an outer diameter (o.d.) as 364 µm.  
A 0.25-cm section of the polyimide coating was burned off by electrical heating for on-
column detection, giving a total capillary length of 48.5 cm with the effective length 40.0 
cm to the detection window.  In all experiments the capillary cassette was thermostated at 
25 °C if not stated otherwise.  Data acquisition was carried out on a Pentium II HP 
personal computer running HP 
3D
CE ChemStation Software by Agilent.  MS data were 
obtained using a Bruker Reflex IV MALDI-TOF mass spectrometer (Bremen/Leipzig, 
46 
 
Germany).  The instrument was equipped with a 3 ns 337 nm nitrogen laser.  Linear 
positive ion mode was used for large proteins.  Igor Pro (WaveMetrics, Lake Oswego, 
OR USA) was used for data processing and presentation for both MS and CE data. 
2.2.2 Chemicals and Reagents 
All solutions were prepared in Millipore Water Purification System (Barnstead, 
Chicago, IL).  Buffers were prepared from reagent grade glacial acetic acid and 
ammonium hydroxide (EM Science, Gibbstown, NJ, USA).  Double-chain surfactant 
didodecyldimethylammonium bromide (DDAB) was purchased from Sigma Aldrich.  
DDAB aqueous solution was prepared by dissolving the reagent in Millipore water at a 
concentration of 0.1 mM.  The use of the phospholipids 1,2-dilauroyl-sn-
phosphatidylcholine (DLPC) capillary wall coating was accomplished by flushing with 
0.1 mM DLPC and 20 mM CaCl2 in 20 mM Tris-HCl, pH 7.4, buffer for 20 min.  Mesityl 
oxide (MO; Aldrich) was used as a neutral marker for EOF measurements.  Lithium 
hydroxide and acetic acid (Aldrich) were used for buffer preparation.  Dithiothreitol 
(DTT; Sigma) was used as a reducing agent.  α-Cyano-4-hydroxy-cinnamic acid (CHCA; 
Sigma) was purified in ethanol according to the recrystallization procedure of Sigma.  
Trifluoroacetic acid (TFA), HPLC-grade methanol, ethanol, and acetone used in the 
CHCA matrix preparation were purchased from Fischer Scientific (Hampton, NH, USA).  
The analyte of interest in this study, the catalytic domain of ARTD-10 (ARTD-10 cat), 
was isolated and purified by our collaborator Dr. Brian Shilton from the Department of 
Biochemistry, Western University. 
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2.2.3 Capillary Pre-conditioning 
Prior to first use, each fresh capillary was preconditioned by flushing (rinsing 
with high pressure, 1 bar) with 0.1 M HCl for 10 min, followed by Millipore water for 5 
min, 0.1 M NaOH for 10 min, followed by Millipore water for 5 min and then running 
buffer for 10 min.  DDAB coating was then formed by flushing the capillary with the 
surfactant solution for 20 min followed by another 10 min of buffer rinsing to flush out 
the excess surfactant.  An additional 10 min voltage application to improve coating 
stability and repeatability is desirous.
20
  In-between runs coatings get replenished and 
regenerated by a short-time flush of surfactant solution followed by a 2 min buffer rinse.  
For used capillaries, preconditioning at the beginning of each day is necessary to remove 
any unwanted impurity left before. 
EOF measurements were performed by injecting a small plug (20 mbar for 3 s) of 
20 mM mesityl oxide (MO) into the capillary followed by a certain period of voltage 
application.  The CE experimental procedures are stated as follows, if not specified 
elsewhere.  Samples dissolved in water were introduced hydrodynamically (50 mbar for 6 
s), followed by an applied voltage of -20 kV.  The detection wavelengths were 200 and 
280 nm for EOF marker (MO) and protein samples, respectively. 
2.3 Results and Discussions 
2.3.1 Optimization of CE Separation Conditions 
From the analytical point of view, CE is regarded as a high-performance 
separation method because of differentiated electrophoretic migration of ions and 
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electrically charged particles on the basis of their charge-to-size ratio.  In order to 
optimize the separation of ARTD-10 cat and its modified counterpart, firstly we have to 
take a look at their structural differences.  Because of the negative charges resulting from 
the pyrophosphate group in the ADPr structure, the mono-ADP-ribosylated form of 
ARTD-10 cat is expected to have less positive total net charges compared to the 
unmodified form.  According to the amino acid sequence of ARTD-10 cat provided by 
Dr. Brian Shilton, the total net charge of the unmodified form was able to be calculated.  
Considered as an ionizable “side chain” of the acceptor amino acid residue, the net 
charge contributed by pyrophosphate at a given pH could be calculated using the 
equation as follows, 
            
  
          
  Equation 2.1 
where pKa values of pyrophosphate were known to be pKa1 = 0.91 and pKa2 = 
2.10 respectively.  Hence, we were able to calculate the total net charge of both the 
unmodified and the mono-ADP-ribosylated forms of ARTD-10 cat and obtain the plot of 
pH vs. calculated charge for ARTD-10 cat and its ADP-ribosylated form (Figure 2.2) 
(raw data for the plot available in Appendix B).  As discussed before, the total net charge 
would then affect the µe values of the analytes.  Models that determine the optimum pH 
for separation by modeling µe as a function of pH were presented in previous works in 
literature, with excellent agreement between theoretical and observed behavior.
21
  
Therefore, through modeling different µe (or migration time) as a function of different pH 
values and manipulation of CE conditions to find out a maximum migration time (Tm) 
difference, we could achieve optimized separation between the unmodified ARTD-10 cat 
and the potential mono-ADP-ribosylated counterpart. 
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Figure 2.2 Plot of pH vs. calculated charges for ARTD-10 cat and its mono-ADP-
ribosylated form. 
2.3.2 Semi-permanent Capillary Coatings for Prevention of Protein 
Adsorption 
The attention in CE protein separation has primarily been focused on (i) tuning 
the BGE including the buffer type, ionic strength, pH and additives, (ii) tailored post-
rinse procedures to detach adhered protein residues and (iii) the optimization of capillary 
wall shielding in order to reduce protein attachment.
19
  As discussed in the first chapter, 
the effective use of capillary coatings to prevent or minimize protein adsorption is of 
essential importance to high-quality protein separations by CE.  ARTD-10 cat, our 
analyte of interest, is composed of 217 amino acids with a calculated MW as 24436.5 Da 
and theoretical pI ~8.98.  For such a basic pI and also relatively large size, the protein 
would generally remain positively charged under most of the CE separation conditions 
and tend to adsorb onto the fused silica capillary inner surface.  Therefore, prevention of 
protein adsorption was necessitated prior to any separation.  As an attractive alternative to 
covalently or permanently coatings, semi-permanent capillary coatings are increasingly 
40
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attractive on account of their analytical efficiency, convenience and simplicity in 
operation.  In the Yeung lab, the best studied types of semi-permanent coatings include 
1,2-dilauroyl-sn-phosphatidylcholine (DLPC) (Figure 2.3 A), sphingomyelin (SM) 
(Figure 2.3 B), and didodecyldimethylammonium bromide (DDAB) (Figure 2.3 C).  
Compared to single-tailed surfactants, these double-chain surfactants form more stable 
bilayers and thus result in more effective shielding of the capillary-wall negative 
charges.
22-24
  Such coatings can be effectively formed and regenerated by simply rinsing 
the capillary with the surfactant solution for a short period of time. 
 
 
Figure 2.3 Structures of three double-chain surfactants: (A) DLPC, (B) SM and (C) 
DDAB. 
The net charge of the surfactant determines the net charge of the resulting 
capillary coating, and in turn the direction and magnitude of the resulting EOF.  That is, 
zwitterionic surfactants DLPC and SM tend to produce a highly suppressed (near-zero) 
EOF, whereas DDAB will result in a cationic coating and generate a strong anodic EOF.  
The highly stable and strongly reverse EOF obtained in a DDAB-coated capillary allows 
rapid and efficient analysis for basic proteins (positively-charged species in acidic 
environments) in particular.
20, 26, 27
  The cationic surfactant DDAB has previously been 
B 
C
  B 
A 
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shown to form semi-permanent coatings that effectively prevent adsorption of cationic 
proteins in fused silica capillaries with inner diameters of 25–75 mm.25  As a basic 
protein with a calculated pI = ~9, ARTD-10 cat would remain positively charged under 
acidic conditions.  Therefore, DDAB was chosen as the capillary coating in order to 
prevent protein adsorption to a maximized extent. 
2.3.3 The Choice of Buffering Ions, Ionic Strength and Separation 
pH 
Optimization of the separation buffer was carried out using a step-by-step 
approach due to the few factors involved (i.e., pH and ionic strength).  Both pH and ionic 
strength influence the protonic equilibrium of ionogenic substances in the electrolyte 
solution and that of fixed charged groups on the surface of the capillary wall, affecting 
the charge density in the electric double layer and, consequently, the zeta potential.  In 
addition, the ionic strength influences the thickness of the electric double layer at the 
interface between the capillary wall and the electrolyte solution, with the result that, 
when the ionic strength increases, the zeta potential and, consequently, the EOF 
decrease.
28
 
In general, CE analyses and separations can be influenced by many factors 
including pH, buffer concentration (ionic strength), buffer composition (buffering cations, 
buffering anions, additives), and the presence of capillary coatings.  Hence, buffer 
selection plays an integral role in CE due to its significant effects on EOF, selectivity, 
efficiency, resolution and even coating stability. 
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Firstly, buffering ions (cation and anion) were determined.  For DDAB coating, 
buffering anions were found to be a key influencing factor of its stability and analytical 
performance.  Previous works have been done to prove the reduction of DDAB coating 
stability and quality caused by the incorporation of ammonium ions into the BGE.  This 
is due to the stronger adsorption of ammonium ions (NH4
+
) onto the negatively charge 
capillary wall compared to other metal cations.  Therefore, to avoid competition with the 
surfactant in the coating procedure, NH4
+
 ions must be avoided in the buffer.
27, 29, 30
  
Comparing other common metal cations used in CE buffers including lithium (Li
+
), 
sodium (Na
+
) and potassium (K
+
), we ended up choosing Li
+
 as the buffering cation.  
This is based on the mobility matching method, namely to reduce electrodispersion 
effects and achieve high efficiency by matching the mobility of the BGE co-ions to the 
solute mobility.  Since ARTD-10 cat is a protein of 24 kDa, a relatively sizable species 
with slow CE mobility, in order to obtain mobility matching we should choose the 
countercation with low mobility.  Showing lower electrophoretic mobility compared to 
sodium and potassium, Li
+
 was therefore selected.  With respect to the choice of 
buffering anions, a major criterion was good buffering capacity within the pH range of 
choice.  Since the cationic DDAB coating favored the analysis of positively charged 
analytes, using acidic buffers in which ARTD-10 cat bears a great amount of net positive 
charges would be advantageous.  Moreover, to obtain large mobility differences 
theoretically between the unmodified and the mono-ADP-ribosylated ARTD-10 cat 
shown in Figure 2.2, acidic conditions especially pH 3~5 buffers were preferentially 
chosen.  As one of the most commonly used CE buffers in this pH range, acetate was 
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selected as the buffering anion.  In sum, we selected lithium acetate as the CE running 
buffer. 
Secondly, the effect of buffer concentration (ionic strength) was studied.  An 
increase of ionic strength in CZE usually results in the decrease in EOF and variable 
decreases in the electrophoretic mobility of analytes, which accordingly leads to the 
potential for modulating the separation selectivity and resolution by varying the buffer 
concentration. On the other hand, the increase of ionic strength also produces higher 
current and Joule heating, which is deleterious to CE separation, and therefore ionic 
strength increases must be balanced against Joule heating.
24
  In our experiments, the 
concentration of lithium acetate buffer was varied from 10 to 100 mM, and the resulting 
capillary electropherograms are shown in Figure 2.4.  The results indicated that the 
observed peak of ARTD-10 cat (marked with asterisk) became sharpened as the buffer 
concentration increased.  Since the protein sample only contained minute amount of 
acetate, which had a weak UV absorbance at 200 nm, the presence of negative peaks at 
higher acetate concentrations (Figure 2.4 A, B) was then caused by the decreased 
absorbance of the initial sample plug (carried by the EOF).  Namely, the negative peak 
can also be regarded as the EOF peak.  At low acetate concentrations, no or very small 
negative peaks were observed (Figure 2.4 C, D).  Instead, significant positive peaks were 
observed, which only appeared with the injection of ARTD-10 cat sample, and were thus 
attributed to absorbance of impurities in the sample.  Also noteworthy is that lowered 
peak intensity was obtained with decreased buffer concentration.  The reasons accounting 
for this observation are deduced to be sample loss caused by increased interactions with 
the capillary coating.  It has been discussed before that analytes might adhere to the 
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capillary wall through electrostatic and hydrophobic interactions in a bare silica capillary, 
and coatings serve to shield the negatively charged capillary surface from the samples to 
prevent adsorption via electrostatic interaction.  However, hydrophobic interactions 
between the samples and the coating still existed and could be promoted by decreased 
ionic strength, resulting in peak broadening and reduced intensity at lower buffer 
concentration.  Overall, 100 mM was determined as the optimal buffer concentration. 
 
Figure 2.4 Effect of buffer concentration on CE analyses of ARTD-10 cat in a DDAB-
coated capillary: (A) 100 mM; (B) 50 mM; (C) 20 mM; (D) 10 mM.  All protein peaks 
are marked with asterisks.  CE conditions: sample concentration at 0.15 mg/mL, 
hydrodynamic injection at 50 mbar for 6 s, pH 4.00 lithium acetate buffer, applied 
voltage -20 kV. 
Thirdly, the effect of buffer pH on the electrophoresis of ARTD-10 cat was 
determined.  Buffer pH represents one of the most important experimental parameters in 
CE by manipulating selectivity in electrophoresis-based separations, since it affects the 
degree of ionization and thus the effective mobility of weakly ionic species. As 
previously shown in Figure 2.2, ARTD-10 cat bears highly net positive charges at acidic 
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pH conditions.  Consequently, as the net charge of these proteins becomes increasingly 
positive with exposure to the increased acidity, there is more adsorption on the fused 
silica capillary surface.  However, such strong cationic character is still favorable in 
avoiding protein adsorption in the presence of the cationic DDAB coating.  The pH of 
100 mM lithium acetate buffer was varied from pH 3.00 to pH 5.00, and the resulting 
capillary electropherograms are shown in Figure 2.5.  The results indicated that the 
observed peak of ARTD-10 cat (marked with asterisk) became sharpened as the buffer 
pH was lowered.  A sharp protein peak was obtained from 100 mM pH 3.00 lithium 
acetate (Figure 2.5 A), with calculated efficiency as 1,060,000 plate/m.  However, it is 
worthwhile to mention the occurrence of a doubly-split peak at pH 5.00 (Figure 2.5 C) 
herein, possibly caused by poor sample quality, conformational change under less acidic 
conditions or the existence of subspecies.  Also, the analysis of certain proteins can 
possibly show numerous challenging properties, e.g. self-aggregation, limited solubility 
and pH stability, strong adsorption to the coating, and other.  To test the sample purity, 
MALDI MS experiments were performed on the ARTD-10 cat sample.  No suspicious 
peaks were observed in the resulting mass spectra (data not shown), clearly showing [M 
+ H]
+
 peak (m/z 24250) [M + 2H]
2+
 peak (m/z 12130) and [M + 3H]
3+
 peak (m/z 8086) 
as the major sample peaks.  In this sense, we were not able to conclude the reasons for the 
observed peak splitting, and further investigations would be required.  Also noteworthy is 
the lowered peak intensity obtained under less acidic conditions, which could possibly be 
attributed to protein adsorption.  Overall, pH 3.00 was chosen as the separation pH due to 
highest peak efficiency observed.  To sum up, 100 mM pH 3.00 lithium acetate was 
determined as our optimal CE conditions. 
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Figure 2.5 Effect of pH on CE analyses of ARTD-10 cat in a DDAB-coated capillary: 
(A) pH 3.00; (B) pH 4.00; (C) pH 5.00.  All protein peaks are marked with asterisk.  CE 
conditions: sample concentration at 0.15 mg/mL, hydrodynamic injection at 50 mbar for 
6 s, 100 mM lithium acetate buffer, applied voltage -20 kV. 
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2.3.4 CE Analysis of ARTD-10 cat 
In this section, the results of several CE analyses of ADP-ribosylation 
modification on ARTD-10 cat will be presented.  Two in-vial ADP-ribosylation 
modification experiments were individually carried out by Dr. Brian Shilton on Jun 2
nd
 
and Jun 3
rd
 in 2011, referred to as ADP-ribosylation 1 and ADP-ribosylation 2 in this 
report (Table 2.1).  The objective of this experiment was compare the CE migration time 
of the observed major protein peaks between the unmodified and the proposed ADP-
ribosylated ARTD-10 cat samples.  To provide further confirmation, two negative control 
experiments were performed in the meantime.  In the first negative control, 3-
aminobenzaminde (3-AB) was added together with NAD
+
 (+inhibitor), while the second 
control was prepared in the absence of NAD
+ 
(–NAD+).  3-AB acts as an effective 
inhibitor of PARPs, due to its benzamide structure that resembles NAD
+
 and interferes 
with NAD
+
-consuming PARP enzymes.
31
 
The untreated ARTD-10 cat, the negative control samples and the treated samples 
were then subject to CE analysis.  A series of capillary electropherograms were obtained 
and they are shown in Figure 2.6.  The characteristic UV profile of proteins, namely the 
strong absorbance of peptide bonds in proteins at around 200 nm in the far UV spectrum, 
could assist in protein identification.
32
  Based on the same UV absorbance patterns, we 
were able to distinguish the ARTD-10 cat peaks (labelled with asterisks) in Figure 2.6 
B~D from the multiple peaks possibly caused by other reagents. 
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Table 2.1 Composition of the ADP-ribosylation reaction mixtures. 
 
  
 
(A) 
untreated 
ARTD-10 
cat 
(B) control 1 
(+ inhibitor) 
(C) 
control 2 
(–NAD+) 
(D) ADP-
ribosylation 
1 
(E) ADP-
ribosylation 
2 
1 M HEPES, pH 7 - 20 µL 20 µL 20 µL 20 µL 
80% glycerol - 40 µL 40 µL 40 µL 40 µL 
1 M  MgCl2 - 2 µL 2 µL 2 µL 2 µL 
0.5 M DTT - 4 µL 4 µL 4 µL 4 µL 
40 mM  NAD
+
 - 25 µL - 25 µL 25 µL 
100 mM 
aminobenzaminde 
- 20 µL - - - 
water 150 µL 39 µL 84 µL 59 µL 59 µL 
ARTD-10 cat, ~5 
mg/mL in 50 mM 
pH 4.5 AmAc 
50 µL 50 µL 50 µL 50 µL 50 µL 
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Figure 2.6 Capillary electropherograms of ADP-ribosylation modification experiments: 
(A) untreated ARTD-10 cat; (B) negative control 1 (+inhibitor); (C) negative control 2 (–
NAD
+
); (D) treated sample 1; (E) treated sample 2.  All protein peaks are marked with 
asterisks.  CE conditions: 100 mM pH 3.00 lithium acetate, hydrodynamic injection at 50 
mbar for 6 s, applied voltage -20 kV. 
Comparing the capillary electropherograms collected for the untreated ARTD-10 
cat (Figure 2.6 A; Tm = 2.00 min) with the treated sample 1 (Figure 2.6 D; Tm = 2.27 
min) and the treated sample 2 (Figure 2.6 E; Tm = 2.16 min), shifts in the protein 
migration time (Tm) were observed.  Such Tm difference could be potentially caused by 
ADP-ribosylation modification.  However, CE results obtained from the two negative 
controls were rather ambiguous and conflicting.  There was no expectation for any shifts 
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in either of the controls (Figure 2.6 D and Figure 2.6 E, compared to Figure 2.6 A), a 
shift was detected in the negative control 1 (+ inhibitor) (Figure 2.6 B; Tm = 2.23 min). 
It is noteworthy that the within-day (using the same capillary and buffers) 
migration time generally showed good reproducibility for three consecutive runs, with 
relative standard deviation (RSD) less than 1%.  Hence, two possibilities could be elicited 
accounting for the conflicting data: (i) the inhibitory effect of 3-AB was invalid; (ii) the 
Tm shift observed was not related to ADP-ribosylation; e.g., the untreated ARTD-10 cat 
interacted with at least one of the component in the reaction mixtures and resulted in 
mobility change.  In either event, one cannot unambiguously conclude the Tm shifts 
observed in Figure 2.6 resulted from ADP-ribosylation modification.  In addition, the 
peaks observed additional to ARTD-10 cat had not been identified.  We decided to 
perform additional experiments to investigate whether the Tm shifts resulted from ADP-
ribosylation and to assign the multiple peaks presented. 
2.3.5 Investigations into Effects of Different Reagents in ADP-
ribosylation Reaction Mixtures  
In this section, we conducted several CE analyses to determine the possible Tm 
shifts caused by other reagents in the ADP-ribosylation reaction mixtures.  This would 
hopefully provide some insights into the cause of the Tm shifts to confirm whether they 
resulted from ADP-ribosylation or not.  More specifically, the reagents (including DTT, 
MgCl2, glycerol, HEPES and NAD
+
; further information available in Appendix C) 
required to perform ADP-ribosylation modification reaction were individually injected 
with the untreated ARTD-10 cat followed by CE analysis.  The resulting capillary 
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electropherograms were shown in Figure 2.7.  Noteworthy is the slightly slower EOF 
observed in this set of experiments compared to that in Figure 2.6.  Generally, such 
minor EOF variation is normal in CE.  No reagent was found to produce complicated 
background peaks. 
To sum up, all of these reagents were either undetectable at 200 nm, or detected as 
neutral/near-neutral molecules in this set of experiments.  Importantly, this observation 
did not account for the multiple peaks observed between 1.8–2.2 minutes in Figure 2.7 B, 
Figure 2.7 D and Figure 2.7 E.  Finally, the reaction mixture for ADP-ribosylation was 
prepared by adding all the reagents at the same time without incubation and analyzed.  
Compared to Figure 2.7, the resulting capillary electropherograms (data not shown) did 
not display patterns of multiple peaks, showing double peaks at most.  We could 
therefore speculate that there might be unknown interactions that created those peaks, 
such as NAD
+
 degradation and cross-reaction. 
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Figure 2.7 Effects of different components on CE migration time of ARTD-10 cat: (A) 
untreated ARTD-10 cat; (B) ARTD-10 cat in 5 mM NAD
+
; (C) ARTD-10 cat in 16% 
glycerol; (D) ARTD-10 cat in 2 mM DTT; (E) ARTD-10 cat in 100 mM HEPES; (F) 
ARTD-10 cat in 10 mM MgCl2.  All protein peaks are marked with asterisks.  CE 
conditions: sample concentration at 0.15 mg/mL, 100 mM pH 3.00 lithium acetate, 
hydrodynamic injection at 50 mbar for 6 s, applied voltage -20 kV. 
Secondly, the possible effect of each component on the Tm shifts of ARTD-10 cat 
can also be reflected in Figure 2.7.  The potential effects of these component reagents 
included increased buffer viscosity (glycerol), increased ionic strength or conductivity 
(MgCl2), unexpected reaction with (NAD
+
 or DTT) and changed buffer pH (HEPES).  
However, the additions of NAD
+
, glycerol, DTT, HEPES and MgCl2 did not result in 
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obvious change in the Tm of ARTD-10 cat peak.  The data collected so far were not able 
to effectively explain the cause of peak shifts.  That is, the effects of different reagents on 
the protein Tm shifts still remained unclear at least for the current CE conditions.  
Therefore, continued investigation into the cause of the observed peak shifts was 
necessary. 
2.3.6 Continued Investigation into the Cause of Protein Migration 
Time Shifts  
Up until this point, no direct experimental evidence proved ADP-ribosylation of 
ARTD-10 cat resulted in Tm change in CE analyses conducted at pH 3.  This is a 
challenging task to achieve due to: (i) the mono-ADP-ribosylation of ARTD-10 cat has 
not been confirmed by other methods; and (ii) there is no prior knowledge on whether the 
charge difference resulted from ADP-ribosylation of ARTD 10 cat is sufficient to cause a 
detectable peak shift in CE migration time at specific conditions.  As mentioned above, 
the charge difference between the modified and unmodified ARTD-10 cat (Figure 2.2) 
was based on the ionization of pyrophosphate, and thus it is justifiable to suspect the 
actually net charge may differ from the predicted value calculated by the pKa values.  
Naturally, the next step was to repeat the CE runs using higher pH buffers, to vary 
ionization of pyrophosphate on the mono-ADP-ribosylated ARTD-10 cat, if there was 
any. 
Using 100 mM pH 5.00 lithum acetate as BGE, it was evident that the Tm shift 
observed for the treated sample became more apparent (Figure 2.8 A) compared to the 
untreated one (Figure 2.8 B).  To continue the previous investigation on the cause of 
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these peak shifts, the reagents were again added separately to the untreated ARTD-10 cat 
for individual CE analysis.  This resulted in another set of capillary electropherograms, in 
which DTT was found to greatly shift the Tm (data not shown).  Therefore, we performed 
a control experiment to confirm the effect of DTT, in which ARTD-10 cat was incubated 
with 2 mM DTT for 12 h at room temperature followed by CE analysis.  The same 
pattern of peak shift was observed with the addition of DTT and in both cases, a peak 
with totally different Tm was detected (Figure 2.8 C).  One possibility accounting for this 
is that the protein became less positively charged under less acidic conditions and 
protein-wall adsorption began to occur despite of the DDAB coating.  However, the 
presence of DTT somehow interfered with this adsorption, and resulted in a peak shift.  
Another possibility is that the protein-DTT interaction resulted in an unidentified cationic 
species with distinctly different Tm value compared to the untreated ARTD-10 cat.  Yet 
we were not able to drive at a final conclusion without further investigations.  Above all, 
it was confirmed that interactions between DTT and ARTD-10 cat were responsible for 
the observed Tm shifts in the capillary electropherograms. 
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Figure 2.8 Capillary electropherograms for examining the effect of DTT on ARTD-10 
cat: (A) treated ARTD-10 cat; (B) untreated ARTD-10 cat; (C) the incubation mixture of 
ARTD-10 cat with 2 mM DTT.  CE conditions: sample concentration at 0.15 mg/mL, 
100 mM pH 5.00 lithium acetate, hydrodynamic injection at 50 mbar for 15 s, applied 
voltage -20 kV. 
To take one step further, we turned to gel electrophoresis (GE) for confirmation.  
Reducing GE is commonly used to further denature proteins by reducing disulfide 
linkages, thus overcoming some forms of tertiary protein folding, and breaking up 
quaternary protein structure (oligomeric subunits) in the presence of a reducing agent 
such as DTT and beta-mercaptoethanol (BME).  In addition to reducing GE, non-
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reducing GE is normally used when native structure is important for further analysis.  
Firstly we applied: (i) untreated ARTD-10 cat (both the one for CE analysis and the stock 
protein solution in the Shilton Lab), (ii) negative control 2 (–NAD+) as well as (iii) the in-
vial incubation mixture of DTT and ARTD-10 cat, on a non-reducing gel, which showed 
us four other bands (A~D) on the left side of the figure in Appendix F.  Similar sample 
band shifts compared to that of the untreated protein were detected in both of the 
circumstances, suggesting the effect of DTT on the mobility change.  Therefore, we 
arrived at the assumption that inter-molecular disulfide linkages existed in ARTD-10 cat 
and DTT acted as a reducing agent.  It was equally possible that DTT had other 
unidentified interactions with the analyte to cause conformational change and/or 
slowdown in mobility. 
To underpin our hypothesis with further evidence and understand the possible 
DTT-sample interactions, experiments on reducing GE using BME as a reducing agent 
were also conducted.  Likewise, we applied: (i) untreated ARTD-10 cat (both the one for 
CE analysis and the stock protein solution in the Shilton lab), as well as (ii) negative 
control 2 (–NAD+) and (iii) treated ARTD-10 cat sample 2, on a reducing gel, which 
gave us the five bands (E~I) on the right side of the figure in Appendix F.  Exactly the 
same shifting patterns of all the sample bands including the untreated ARTD-10 cat band 
were observed.  To sum up, DTT’s effect on ARTD-10 cat was confirmed by CE and 
non-reducing GE, and was revealed to be the reduction of disulfide bond by reducing GE.  
The existence of disulfide bridge(s) in ARTD-10 cat therefore confirmed, yet further 
investigation has to be carried out to find out the number of disulfide bonds as well as to 
characterize their sites. 
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Last but not least, the band upshifts observed in non-reducing GE resulting from 
the addition of DTT, were once postulated to be an indication of auto-modification in a 
master thesis from our colleagues in Germany.  It was thereby believed that their 
conclusion was incorrect due to the omission of DTT’s effect (further reading available in 
Appendix D and Appendix E).  The sequence for ARTD-10 cat provided by Dr. Brian 
Shilton is as follows (possible disulfide-formation sites on cysteine are labeled in red 
color; possible cleavage sites by trypsin digestion treatment on arginine and lysine are 
underlined): 
MAGQTLKGPW NNLERLAENT GEFQEVVRAF YDTLDAARSS 
IRVVRVERVS HPLLQQQYEL YRERLLQRCE RRPVEQVLYH 
GTTAPAVPDI CAHGFNRSFC GRNATVYGKG VYFARRASLS 
VQDRYSPPNA DGHKAVFVAR VLTGDYGQGR RGLRAPPLRG 
PGHVLLRYDS AVDCICQPSI FVIFHDTQAL PTHLITCEHV 
PRASPDDPSG AHHHHHH 
It is, therefore, justifiable to assume the potential explanation for the interaction 
between ARTD-10 cat and the reducing agents (DTT and BME) is the breakage of the 
disulfide linkage, which is yet to be confirmed by several approaches such as MS 
analysis subsequent to tryptic digestion. 
2.3.7 MALDI MS Analysis of ADP-ribosylation 
Mono-ADP-ribosylation of peptides and proteins is calculated to yield a 541.1 Da 
(the net mass gain resulting from the attachment of ADPr) increase in the monoisotopic 
mass of peptides and a 541.3 Da increment in the average mass of full-length proteins.
33
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Theoretically, the calculated MW for ARTD-10 cat is 24436.5 Da, leading to 24977.8 Da 
for that of the mono-ADP-ribosylated form.  For such a big modification, MALDI MS is 
theoretically capable of discriminating between the modified and the unmodified form 
judged by a large difference in m/z values. 
MS analysis may suffer from endogenous compounds in the form of ion 
suppression: a form of matrix effect that negatively influences the sensitivity of the mass 
spectrometric detection.  Therefore, it is necessary to perform sample clean-up or pre-
treatment prior to MS analysis especially for sample from complicated biological sources.  
Therefore, prior to MALDI MS identification, the samples may also need to be desalted 
and concentrated, and this is most frequently accomplished by using commercially 
available reverse phase C18/C4 Ziptip (pipette tips containing C18 or C4 resin).  
Therefore, in order to obtain a better MS signal, we referred to Ziptip micropipette 
desalting techniques.  ZipTip C4 tips are appropriate for proteins of low to intermediate 
MW, proteins over 100,000 Da, which is exactly the case for the analysis of ARTD-10 
cat protein.  The C4-Ziptip-desalted treated and untreated (with in vitro mono-ADP-
ribosylation attempts) ARTD-10 cat samples were applied to MALDI MS analysis 
individually, and the resulting mass spectra are shown in Figure 2.9.  By comparison of 
the major peaks between the treated and the untreated protein samples, the selected [M + 
H]
+
 and [M + 2H]
2+
 peaks displayed almost the same m/z profiles, showing no indication 
of modification.  Noteworthy is the experimentally obtained MS of ARTD-10 cat was 
approximated 200 Da smaller than the theoretical one, which required further 
biochemical studies to explain. 
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Figure 2.9 MALDI mass spectra of C4 Ziptip-desalted ARTD-10 cat samples: (A) 
negative control 2 (–NAD+); (B) treated ARTD-10 cat 2. 
2.4 Conclusions 
CE takes an active part in current analytical field especially for studies on 
biomolecules, contributed by its versatility in and distinguished performance in 
conventional analyses.  There is an extensive body of literature on PARP recent years, 
among which CE-related publications have not been reported.  This study has been 
undertaken to present efforts toward CE studies of ADP-ribosylation modification.  The 
MALDI-MS data was also a good supplement to our evidence, denoting no sign of ADP-
ribosylation modification on the sample.  Collectively, these data indicate that the 
attempts for ADP-ribosylating ARTD-10 were not successful.  We also confirmed that 
DTT was accounted for both Tm differences in CE and band shifts in GE, which were 
14
12
10
8
6
4
2
0
1
0
3
30252015105 x10
3
 
In
te
n
s
it
y
 (
Io
n
 C
o
u
n
ts
)/
[M+2H]
2+
[M+H]
+
[M+3H]
3+
m/z
14
12
10
8
6
4
2
0
1
0
3
30252015105 x10
3
 
[M+3H]
3+
[M+2H]
2+
[M+H]
+
In
te
n
s
it
y
 (
Io
n
 C
o
u
n
ts
)/
m/z
12129.40 
24248.46 
8086.73 
8087.39 
12130.36 
24256.60 
A 
B 
70 
 
resulted from reduction of the disulfide bridge(s) in ARTD-10 cat.  However, there 
existed some observations that could not been explained so far, such as the double peak 
of ARTD-10 cat presented at pH higher than 5 and the observed 200 Da smaller MW in 
MS compared to the theoretical MW.  This work has brought some light on the analysis 
of ARTD-10, yet a substantial amount of work has to be done to fully resolve the PARP 
biochemistry.  Further validation of the interactions between DTT and ARTD-10, most 
possibly disulfide linkages, is necessitated to acquire a conclusive remark.  
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Chapter 3. In-Capillary Derivatization: Miniaturized 
Methyl Esterification of Phosphopeptides 
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3.1 Introduction 
As one of the most significant and prevalent protein PTMs, reversible protein 
phosphorylation plays a crucial role in a broad range of biological functions including 
modulation of enzymatic activity, subcellular localization, intra- and inter-molecular 
protein interactions, and also cellular processes such as intracellular signal transduction, 
cell differentiation and progression through the cell cycle.
1
  The analysis of protein 
phosphorylations, however, is not a straightforward process.  Detection of 
phosphopeptides and characterization of single or multiple phosphorylation sites of 
phosphoproteins poses challenges for instrumental techniques, along with several 
complications needed to be addressed.  In the complex cellular milieu, phosphoproteins 
are present in very low copy numbers, and only a small fraction of any given protein is 
phosphorylated at any given time.  Moreover, specific phosphorylated sites on a protein 
may vary and/or can be only partially phosphorylated. 
As a main-stream technique for unbiased protein analysis in particular the 
characterization of protein PTMs, mass spectrometry (MS) is routinely utilized for the 
identification of protein phosphorylation especially for the large-scale study of protein 
phosphorylation, i.e. phosphoproteomics.  Nonetheless, mass spectrometric identification 
of phosphorylated peptides and proteins is relatively challenging due to their low 
abundances, incomplete peptide coverage of the proteolytically cleaved proteins as well 
as suppressed ionization in the presence of other non-phosphorylated peptides in high 
abundances.  Also, phosphorylated peptides with low stoichiometric levels for a given 
protein are therefore overshadowed by their unmodified counterparts.  Phosphopeptide 
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detection suffers from low relative ionization efficiency in positive ion mode and 
generally lower sensitivity in the negative ion mode.  Hence, developing new MS-
compatible methods for the enrichment and isolation of phosphopeptides from complex 
mixtures aimed at the assignment of phosphorylation sites remains to be a key issue for 
many research groups worldwide.  Significant advances in both phosphopeptide 
enrichment methods and sensitive MS instrumentation have been achieved over the past 
decade to facilitate the progressing of phosphoproteomics.  Mainstream strategies 
encompass physical fractionation of tryptic digest of complex peptide mixtures by strong 
cation exchange (SCX) chromatography; phosphopeptide enrichment by metal oxide 
affinity chromatography (MOAC), immobilized metal ion affinity chromatography 
(IMAC), or the use of chemistry-based derivatization strategies to introduce stable 
affinity tags on the phosphate groups.  Among all the affinity-based methods, IMAC has 
proven very successful in providing near complete enrichment of phosphorylated 
peptides and contributes largely to the success of proteome-wide profiling of 
phosphoproteins.
2
 
Recent developments for MS-based phosphoproteomics highlight an area of 
considerable interest: the introduction of suitable derivatization procedures to increase 
detection sensitivity, to promote sample ionization and hence the detection of 
phosphorylated peptides, or even to increase the information content of a fragment 
spectrum.  As a common derivatization strategy, methyl esterification has been applied to 
peptide and protein quantitation, de novo sequencing and reducing non-specific binding 
of acidic amino acid residues prior to IMAC for enrichment of phosphorylated peptides.
3
 
Methyl esterification of a peptide converts carboxylic acids, such as those present on the 
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side chains of acidic amino acid residues aspartic acid, glutamic acid as well as the free 
carboxyl terminus (C-term), to their corresponding methyl esters in the presence of a 
suitable acidic catalyst, as illustrated in Figure 3.1. 
 
Figure 3.1 General reaction scheme of methyl esterification; the top reaction shows the 
formation of anhydrous MeOH-HCl; the bottom reaction shows the methyl esterification 
of free carboxyl groups. 
where methanolic hydrochloride (MeOH-HCl; hydrochloric acid in anhydrous 
methanol) is prepared as both an esterifying agent and an acidic catalyst.  In addition to 
improving MS/MS fragmentation efficiency and sequence coverage, the conversion of 
peptide carboxylates to their corresponding methyl esters has been shown to sharply 
reduce non-specific binding in IMAC towards acidic peptides, enhancing the selectivity 
for phosphopeptides.
3, 4
  Notably, methyl esterification has been used in previous studies 
to increase specificity for the selective detection of phosphopeptides in negative ion mode 
by hybrid quadrupole time-of-flight (Q-TOF) MALDI MS.
5
 
Advanced bioanalytical techniques require appropriate analytical protocols with 
adequate sensitivity and selectivity, and meanwhile minimize sample or reagent 
consumption.  With this in mind, it is highly appreciated to develop miniaturized 
analytical and sample processing systems.
6
  Microreactors, which are referred to 
miniaturized reaction systems in which chemical reactions take place in fluid channels, 
facilitate the conduction of chemical processes with volumes typically in the sub-micro- 
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to sub-milliliter range.  The major requirements for microreactors include (i) easy and 
reproducible mixing, (ii) negligible evaporation, and (iii) simple interfacing with 
sensitive and informative analytical tools.
7
  A capillary or a narrow channel could 
therefore serve as an attractive medium for performing miniaturized reactions, acting as 
not only a microreactor for carrying out a reaction at sub-microliter (sub-µL) or nanoliter 
(nL) levels but also a separation column to fractionate the analytes prior to subsequent 
analysis.
8
 The interfacing of microfluidic devices such as CE with MS detection therefore 
attracts broad attention in the recent development of the phosphoproteomics. 
Performing the in-capillary methyl esterification reaction presents the advantages 
of low sample and reagent consumption, aiding in the miniaturization of the reaction.
9
  
The work presented here aims to investigate and hopefully resolve a number of 
challenges associated with in-capillary methyl esterification.  The first challenge is the 
extremely acidic reaction conditions which can potentially damage the instrument 
components.  The second one is that the reaction must be performed in a water-free 
environment, in the light of the reversibility of the reaction in the presence of water.  As a 
traditional approach to manipulate the capillary wall charge, capillary coatings, however, 
are typically sensitive to organic solvents and very likely to be seriously damaged in the 
presence of methanol used in common methyl esterification method.  Hereby, 
preliminary efforts towards in-capillary methyl esterification of phosphorylated peptides 
for MALDI MS analysis along with on-capillary-tip sample recovery after removal of 
unfavorable organic solvents were presented, in an attempt to develop subsequent in-
capillary recapture and enrichment of target molecules by means of either dynamic pH 
junction or solid phase extraction using immobilized magnetic beads. 
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3.2 Experimental Section 
3.2.1 Apparatus 
 All CE-related experiments were performed with an Agilent 3D-CE Capillary 
Electrophoresis Instrument (Palo Alto, CA, USA).  Uncoated fused-silica capillaries were 
purchased from Polymicro Technologies (Phoenix, AZ, USA).  The capillary dimensions 
were 50 µm in inner diameter, 360 µm in outer diameter with a total length of 48.5 cm. 
MALDI mass spectrometric data was obtained using the following two 
instruments.  A 4700 Proteomic Discovery System MALDI TOF/TOF MS (Applied 
Biosystems, Farmingham, MA) was used to perform MS analyses for the experiments on 
β-casein tryptic digest.  The instrument is equipped with a 355-nm Nd:Yag laser.  
Reflectron and positive ion mode were chosen for the detection of peptides.  All voltage 
settings were left at the default values preset by Applied Biosystems.  Peptides were 
acquired over the range m/z 500–3500.  Mass spectra were recorded as sums of 1000 
shots under video monitoring in all experiments, if not specified elsewhere. 
A Bruker Reflex IV MALDI-TOF MS (Bremen/Leipzig, Germany) was also used 
to perform MS analyses on the methyl esterified β-casein tryptic digest.  The instrument 
is equipped with a 337-nm nitrogen laser.  Reflectron mode was used for the detection of 
peptides with both positive and negative ion modes.  All voltage settings were left at the 
default values preset by Bruker.  Mass spectra were recorded as sums of 100 shots under 
video monitoring in all experiments, if not specified elsewhere.  Calibration was 
conducted using standard peptide mixtures.  Peptides were acquired over the range m/z 
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500–3500.  Igor Pro (WaveMetrics, Lake Oswego, OR, USA) was used for data 
processing. 
3.2.2 Chemicals and Reagents 
Anhydrous methanol was purchased from Sigma Aldrich (St.  Louis, MO, USA) 
and was used in capillary preconditioning and methyl esterification reactions.  Acetyl 
chloride was purchased from Fluka and was used as a source of protons in the methyl 
esterification reaction.  For the initial experiments a model peptide was chosen instead of 
using a phosphorylated protein digest.  Angiotensin I (AI) and angiotensin II (AII) 
(Sigma Aldrich) were selected as model peptides due to low cost and the presence of two 
possible sites of methyl esterification.  Monophosphorylated peptide was obtained from 
tryptic digestion of β-casein from bovine milk (Sigma Aldrich) with sequencing grade 
modified trypsin (Promega, Madison, WI).  The tryptic digestion was performed at the 
volume of 1 mL with 1 mg of β-casein from bovine milk and 20 μg trypsin at an enzyme-
to-substrate ratio of 1:50 (w/w) in 50 mM pH 8 ammonium bicarbonate and 2 mM 
calcium chloride and set overnight at 37 °C.  After digestion, TFA was added into the 
sample solution at 1% to quench the reaction and the resulting solution was then 
lyophilized to dryness, diluted in water at a 2 mg/mL concentration, and stored in the 
freezer (-20 °C).  Deionized water was obtained from a Millipore purification system 
(Bedford, MA, USA).  α-Cyano-4-hydroxy-cinnamic acid (CHCA; Sigma) was chosen as 
the MALDI matrix and purified in ethanol according to the recrystallization procedure of 
Sigma.  Trifluoroacetic acid (TFA), HPLC-grade methanol, ethanol, and acetone used in 
the CHCA matrix preparation were purchased from Fischer Scientific (Hampton, NH, 
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USA).  Diammonium citrate was included in the CHCA matrix due to previous discovery 
that it can contribute to more complete peptide mapping coverage of the casein sequence 
and also enhanced signal response of the phosphorylated peptides.
10
  The 2 M methanolic 
hydrochloride (MeOH-HCl) solution was freshly prepared by dropwise addition of 160 
μL of acetyl chloride, while stirring under a ventilation hood, to 1 mL of anhydrous 
methanol. 
3.2.3 Capillary Preconditioning 
Prior to use, a new capillary was flushed (1 bar) with anhydrous methanol for 30 
min.  It is indispensable that all water from the peptide solutions be removed prior to the 
addition of the esterification reagent to obtain complete conversion of carboxylic groups 
to methyl esters and reduce side products.  In other words, a water-free environment is 
crucial to the successful conversion of a peptide to its corresponding methyl ester.  As a 
consequence, the typical capillary pre-treatment of flushing the capillary with aqueous 
solutions was not employed.  Between runs, the capillary was flushed with anhydrous 
methanol for at least 30 min.  After use, the capillary was flushed with anhydrous 
methanol for 30 min and stored with the ends of the capillary in vials of methanol. 
3.2.4 Methyl Esterification 
3.2.4.1 In-Vial Methyl Esterification 
To selectively convert carboxylate groups of peptides to methyl esters, 2 M 
MeOH-HCl solution was prepared following a well-established literature protocol 
developed by Ficarro et al.
11
  In short, 160 µL of acetyl chloride was added drop-wise to 
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1 mL of anhydrous methanol.  Due to the large amount of heat generated, the reagent was 
then allowed to sit for 5 min at room temperature before being used.  This formula can 
either be scaled up or downsized according to different requirements, as long as the same 
acetyl chloride to anhydrous methanol ratio is maintained.  Fresh solutions of MeOH-HCl 
were prepared for each day’s use. 
In-vial reactions were performed by direct addition of MeOH-HCl to a 0.6 mL 
PCR vial containing dried (by SpeedVac, a centrifugal vacuum concentrator) peptides 
angiotensin I (AI) and angiotensin II (AII).  The vial was capped and reactions were 
allowed to proceed for different lengths of time at room temperature.  Once the reaction 
time was reached, solvent was removed in SpeedVac, and the resulting dried peptides 
were redissolved in water.  A portion (2 µL) of sample solutions was mixed with 2 µL of 
the matrix solution, in a 1:1 (v/v) ratio, and an aliquot of 0.73 µL was spotted onto the 
MALDI target and dried at atmospheric pressure, followed by MALDI MS analysis. 
Timed experiments were conducted in a similar manner.  Dried peptide samples 
were resuspended and incubated for variable time periods (20 min, 40 min, 60 min and 2 
h) in the presence of 2 M MeOH-HCl at room temperature.  The reaction mixtures were 
then dried and redissolved in water or other appropriate solvents for subsequent MALDI 
MS analysis.  Samples were analyzed by MS to determine the extent of methyl 
esterification of acidic groups as a function of time, as well as to identify side products. 
3.2.4.2 In-Capillary Mixed Methyl Esterification 
The capillary was first flushed with high pressure (1 bar) for 30 min with 
anhydrous methanol to remove any trace of water present inside the capillary.  In view of 
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the strong acidity and erosiveness of the esterification reagents, it is preferential to 
perform CE injections from outside the instrument in order to protect the electrodes as 
well as the interior parts of the instruments.  Noteworthy is that it is recommended to 
have the liquid level of the buffer surface in the inlet side at the same height as the tip of 
the capillary at the outlet to avoid unwanted siphoning.
12
  After fresh MeOH-HCl was 
prepared, a short plug of peptide dissolved in anhydrous methanol was injected (10 s, 50 
mbar) followed by another plug of MeOH-HCl (10 s, 50 mbar).  This sequence was 
repeated in alternating plugs which were 1 cm long with 10 of each plug for a total of 20 
plugs.  The reaction was then allowed to proceed for specific time periods.  Once the 
reaction time was reached, low pressure (50 mbar) was applied to mobilize the capillary 
content onto the MALDI target. 
3.2.5 MALDI Conditions and Spotting from Capillary 
To transfer the sample band from the capillary onto the MALDI sample plate, the 
cathodic end of the capillary was repositioned outside the instrument, while the anodic 
end remained inside the instrument.  Elution of the capillary content was performed by 
applying a constant pressure (50 mbar) at the capillary inlet in 20-s intervals, yielding 35 
nL fractions which were manually deposited onto the sample plate pre-spotted with 
matrix.  A schematic of this method is shown in Figure 3.2.  Briefly, once the reaction is 
complete, the outlet is placed outside the instrument and low pressure was used to 
mobilize the product toward the outlet where it was spotted onto the MALDI target.  The 
DHB was prepared from a literature procedure and applied to the MALDI target in two 
layers (0.5 µL base layer, and 0.2 to 0.05 µL top layer, then sample).
13
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Table 3.1 Three-layer CHCA sample spotting method. 
1
st
 layer 0.5 μL 5 mg/mL CHCA in 4:1 acetone:methanol 
2
nd
 layer 0.25 μL Saturated CHCA in 3:2 water:methanol 
3
rd
 layer 35 nL Sample 
 
 
Figure 3.2 Schematic of spotting from outside of the CE instrument. 
3.2.6 On-Capillary-Tip Hanging Droplet Reaction 
Despite the advantages offered by in-capillary mixing, there remained concerns 
about the mixing efficiencies solely by diffusion.  Therefore, a new experimental design 
taking advantage of the CE instrumental set-up was proposed: immediately after 
alternating bands of reactants (peptides and MeOH-HCl) are introduced into the capillary, 
high pressure will be applied to flush the capillary contents into a hanging droplet at the 
capillary tip to guarantee complete mixing.  To be more specific, one end of the capillary 
is placed outside of the instrument through the entire process, and the hanging droplet 
which contains the anhydrous reagents is kept in a capped vial to maintain the sealed 
environment to prevent any water contamination from the open air.  Once the reaction 
time was reached, the hanging droplet was carefully transferred to a clean PCR tube and 
Two-layer Matrix Pre-coated
MALDI MS
Pressure
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Speed-vas was used to evaporate the organic solvents, simply to test the degree of 
completeness for the esterification by subsequent MALDI MS analysis. 
3.2.7 On-Capillary-Tip Droplet Sample Recovery Test 
Up until this point, there were well-established methods to perform methyl 
esterification inside capillary.  Due to the labor-consuming process of recollecting the 
hanging droplet back into a vial to enable sample drying, another method can be applied 
to facilitate subsequent CE separation and enrichment combined with removal of excess 
methanol and HCl.  That is, the esterified products can be directly dried at the capillary 
tip as a hanging droplet, by the aid of a nitrogen flow.  After complete removal of any 
remanent solvent, a droplet of buffer was directly pipetted onto the capillary tip and sat 
for 30 s, and the peptide recovery would be evaluated in MALDI MS using recovery 
buffers of different composition: 50% acetonitrile (ACN), 1% TFA, 10 mM pH 9 
ammonium acetate (AmAc), 50% ACN in 10 mM pH 9 AmAc. 
3.3 Results and Discussion 
Through examination of the derivatization effectiveness and efficiency for three 
types of experimental set-up, peptide samples used in this work included angiotensin I 
(AI) and angiotensin II (AII) as model peptides, and β-casein tryptic digest as the source 
of phosphopeptide.  For the sake of convenience, it is necessary to list the data selected 
corresponding to different types of methyl esterification attempts as follows. 
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Table 3.2 Data chosen for showing the methyl esterification results in this work.  Peptide 
samples used for conducting methyl esterification derivatization corresponding to types 
of experiments are listed. 
Methyl Esterification 
Attempts 
In-Vial In-Capillary Mixing 
On-Capillary-
Tip 
1 h Reaction 
Time 
1 h Reaction 
Time 
Timed 
Experiment 
1 h Reaction 
Time 
Model peptides 
(AI & AII) 
✓ ✓  ✓ 
β-Casein tryptic digest ✓  ✓  
 
3.3.1 Effectiveness of Methyl Esterification 
3.3.1.1 In-Vial Reaction 
The value of an attractive derivatization approach is affected by the speed and 
completeness of the reaction, the occurrence of undesirable byproducts, and ease of 
reagent removal.
14
  High conversion ratio of derivatization reaction remains to be a major 
requirement.  This is particularly true when it comes to methyl esterification of 
phosphorylated peptide in consideration of reducing the complexity of MS signals.  
Therefore, through our initial experiments, the in-vial chemistry of methyl esterification 
was tested first using angiotensin I (AI) and angiotensin II (AII) as model peptides. 
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Figure 3.3 MALDI mass spectrum of in-vial methyl esterification for AI and AII.  
Peptides were at the concentration of 0.05 mg/mL. 
After 1 h of incubation, high-abundance peaks were observed with m/z 1074 and 
m/z 1324 at as is shown in Figure 3.3.  The peptide sequence for AI and AII are 
DRVYIHPFH and DRVYIHPF, with calculated monoisotopic peaks [M + H]
+
 of 
1296.48 and 1046.18, respectively.  With a mass increment of 14 Da introduced by each 
conversion of the carboxyl to its methyl ester, the mass shifts of 28 Da in both derivatized 
peptides are thus indicative of the formation of two methyl esters in each peptide: one at 
the side chain of D and one at the C-term.  Thus, the peaks at m/z 1310 and m/z 1060 are 
indicative of the singly esterified AI and AII respectively, and the peaks at m/z 1324 and 
m/z 1074 correspond to the doubly (fully) esterified AI and AII, respectively.  The high 
peak intensities of doubly methylated AI and AII indicate high conversion rates of the 
derivatization for both model peptides. 
In addition to the model peptides, evaluation of the in-vial methyl esterification 
effectiveness was further extended to peptide mixtures obtained from the tryptic digest of 
the phosphoprotein β-casein.  β-Casein is chosen as a source of two phosphorylated 
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peptides after proteolytic digestion: one monophosphorylated peptide at m/z 2061.82, and 
one tetraphosphorylated peptide at m/z 2966.16, usually found with one missed cleavage 
(m/z 3122.26 with a leading arginine at N-terminal).  A list of peptides from β-casein 
tryptic digest are listed as follows in Table 3.3, with the calculation of [M + H]
+
 for the 
original peptides and the anticipated fully methyl esterified counterparts. 
Table 3.3 Peptides commonly identified from the tryptically digested β-casein, in the 
increased order of molecular mass.  Amino acid residues that are possible esterification 
sites are labeled in blue color with “m” representing the addition of methyl groups via the 
derivatization. 
In the circumstance of real application in phophopeptide detection after methyl 
esterification, the resulting decrease in heterogeneity will maximize phosphopeptide 
signal intensity in MS.  Furthermore, gaining better understanding of these minor but 
Peptide Sequence [M + H]
+
 Expected Fully Methyl Esterified Products 
Calculated 
[M + H]
+
 
EAMAPK 646.32 mEAMAPKm 674.35 
VLPVPQK 780.49 VLPVPQKm 794.51 
GPFPIIV 742.45 GPFPIIVm 756.47 
EMPFPK 748.37 mEMPFPKm 776.40 
AVPYPQR 830.45 AVPYPQRm 844.47 
YPVEPFTER 1137.55 YPVmEPFTmERm 1179.60 
LLYQEPVLGPVR 1383.65 LLYQmEPVLGPVRm 1411.68 
HQGLPQEVLNENLLR 1759.94 HQGLPQmEVLNmENLLRm 1801.99 
FQSEEQQQTEDELQDK 1981.56 FQSmEmEQQQTmEmDmELQmDKm 2079.67 
FQ(pS)EEQQQTEDELQDK 2061.82 FQ(pS)mEmEQQQTmEmDmELQmDKm 2159.93 
DMPIQAFLLYQEPVLGPVR 2186.16 mDMPIQAFLLYQmEPVLGPVRm 2228.21 
RELEELNVPGEIVE(pS)L(pS)
(pS)(pS)EESITR 
3122.26 
RmELmEmELNVPGmEIVmE(pS)L(pS)(pS
)(pS)mEmESITRm 
3234.39 
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unavoidable side products which can be generated by the esterification chemistry will aid 
peak assignment and database searching of MALDI MS data.  The tryptically digested β-
casein was therefore selected as a standard peptide mixture to evaluate the potential for 
the methyl esterification on phosphorylated peptides as well as the derivatization 
effectiveness on a variety of peptides.  Figure 3.4 displays a series of magnified MALDI 
mass spectra to show the individual in-vial methyl esterfication result for six peptides 
respectively. 
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Figure 3.4 MALDI mass spectra showing the enlarged profiles of selected six peptides 
from 0.02 mg/mL β-casein tryptic digest after in-vial methyl esterification: (A) GPFPIIV 
(m/z 742.45); (B) AVPYPQR (m/z 830.45); (C) YPVEPFTER (m/z 1137.55); (D) 
LLYQEPVLGPVR (m/z 1383.65); (E) FQ(pS)EEQQQTEDELQDK (m/z 2061.82); (F) 
DMPIQAFLLYQEPVLGPVR (m/z 2186.16).  Esterification sites are labeled in blue 
color in the peptide sequences with “m” representing the addition of methyl groups, and 
deamidation sites are labeled in red color. 
Peptide GPFPIIV ([M + H]
+
  m/z 742.45) displays no signal of underivatized peak 
but a predominant signal at m/z 756.47, suggesting an effective conversion to the 
corresponding methyl ester on the C-term (Figure 3.4 A).  Likewise, peptide 
YPVEPFTER ([M + H]
+
  m/z 1137.55) also exhibits a high conversion rate with only 
small amount of doubly esterified products and considerably high intensity of triply (fully) 
esterified peak (Figure 3.4 C). 
It is also seen in these mass spectra that certain peptide species gave rise to peaks 
with a mass shift of 15 Da from the fully derivatized products.  Since the formation of 
methyl esters results in and increase of 14.03 Da in mass for each carboxylate group 
present, the most possible explanation for this unusual mass increment was deamidation 
of the asparagine residue, which, by conversion to an aspartate residue, would increase 
the mass by 0.985 Da (-NH2 to -OH).  It has been suggested that under the harsh 
condition used for esterification the expected deamidation reaction may take place, 
yielding the plus-15 Da products.
10, 15
  Overall speaking, during the reaction process, 
esterification and deamidation can occur on acidic or amide-containing amino acid 
residues, and the C-terminal amide group, leading to mass shift of 14 or 15 Da for each 
conversion.
3, 15
  Amino acid residues containing carboxamide groups (N/Q) are located in 
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several peptide fragments in the β-casein tryptic digest.  As illustrated by Figure 3.4 B, 
for peptide AVPYPQR ([M + H]
+
 m/z 830.46), esterification went to completion for all 
the carboxylate moieties and that negligible traces of the underivatized peptides are 
present in the mass spectrum.  In the presence of one Q residue, another mass shift of 15 
Da was expected.  Similarly, peptide LLYQEPVLGPVR with [M + H]
+
 at m/z 1383.65, 
presents an almost complete conversion to its fully esterified counterpart with no 
presence of underivatized signal (Figure 3.4 D).  A characteristic mass shift of 15 Da 
along with abnormal isotopic distribution was observed, an indicator of the deamidation-
methyl esterification reaction occurring at the amide group of the Q residue present in the 
sequence.  With three possible esterification sites in the peptide sequence 
DMPIQAFLLYQEPVLGPVR, which gives the monoisotopic peak ([M + H]
+
) at m/z 
2186.16, the corresponding triply esterified product at m/z 2228.19 was observed, 
together with the detection of a doubly esterified peak of minor intensity at m/z 2214.20 
(Figure 3.4 F).  Sodium adducts of small intensities were detected as well.  Nonetheless, 
high-intensity peaks of the deamidation products were observed with two consecutive 
mass shifts of 15 Da at m/z 2243 and 2258 in the presence of two Q residues in the 
sequence. 
Another issue that enhances complexity of MALDI mass spectra is the formation 
of metal ion adducts.  During UV excitation, several reactions are known to occur in the 
MALDI source: formation of radical cations via electron-transfer, generation of singly 
charged ions via protonation, and production of cationized molecules in the form of metal 
ion adducts.
16
  The observation of metal ion adducts, mostly with alkali metal ions such 
as sodium and potassium, became more pronounced for low-intensity species.  This is 
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specially the case for the monophosphorylated species FQ(pS)EEQQQTEDELQDK ([M 
+ H]
+
 m/z 2061.82) that we are most interested in, yielding a fully methyl esterified peak 
at m/z 2159.96 with all seven of its esterification sites being converted to methyl esters 
(Figure 3.4 E).  However, the presence of five Q residues also contributed to the 
complication of the mass spectrum, giving rise to deamidation products at m/z 2175.00 
and m/z 2189.95 or even at m/z 2197.25 as a combination of both side reaction and 
sodium adduct [M + Na]
+
.  Furthermore, the predominant signal at m/z 2182.25 was 
deduced to be merely a sodium adduct of the fully derivatized peak with a mass shift of 
22 Da.  The overwhelmed signal of our target peptide by its sodium adduct can be 
detrimental to mass spectrometric quality and in the long term, the effectiveness of 
peptide mapping after methyl esterification. 
3.3.1.2 In-Capillary Reaction 
After the investigation of the in-vial methyl esterification effectiveness, the next 
step is to explore the application of the in-vial chemistry in a miniaturized manner using 
CE instrumentation.  An advantage to performing the esterification inside a capillary is 
that the removal of organic solvents prior to MS analysis can be exempted.  This is 
because the spot volume with the in-capillary method (35 nL) was much smaller 
compared with the in-vial approach (0.25 µL).  In contrast, it is impossible to obtain MS 
data when the reaction mixture is simply pipetted onto the pre-spotted matrix.  Another 
advantage of using the capillary as a miniaturized reaction vessel is the lowered detection 
limit and thereby enhanced detection sensitivity in comparison to traditional MALDI-MS 
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spotting method, possibly attributed by the sub-microliter amount of sample spotted and 
minimization of sample loss. 
In-capillary incubated methyl esterification was proposed in a previous master 
thesis in which the reactants were mixed in a vial prior to injection into a capillary such 
that the capillary was essentially treated as a reaction vessel only.
9
  It was reproduced in 
this work and comparable results were obtained in terms of the esterification 
completeness (data not shown).  However, to further lower down the sample consumption 
and take full advantage of CE instrumentation, an attempt for in-capillary mixed reaction 
was also explored.  Initial study on in-capillary mixing has been presented in a former 
master student’s work, in which mixing by pressure application and by voltage 
application were respectively attempted.
9
  Transverse diffusion of laminar flow profiles 
(TDLFP) is considered as a generic approach for mixing reactants inside a capillary 
microreactor and in-capillary mixing of the reagents by diffusion was attempted.
7
  Simply, 
the experimental design of in-capillary mixing and incubation was performed by 
hydrodynamic injection of alternating bands of peptides and MeOH-HCl.  In the course 
of successive injections, alternating sample zones and reagent zones can be ideally mixed 
by transverse diffusion so that they react with each other, as depicted in Figure 3.5. 
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Figure 3.5 Schematic of in-capillary methyl esterification.  Injections of reactants were 
performed as alternating bands of MeOH-HCl and peptides dissolved in anhydrous 
methanol, subsequently mixed by diffusion and subject to in-capillary incubation. 
The resulting products were subject to off-line MALDI MS analysis via the 
application of constant pressure (50 mbar) at the capillary inlet for 20 s, yielding a 35 nL 
volume fraction per sample spot.  Figure 3.6 illustrates the resulting MALDI mass 
spectrum from the in-capillary methyl esterification after 1 h of reaction time on model 
peptides AI & AII.  The absence of native peptide(s) indicates a complete reaction.  
Predominant signals of fully methyl esterified peptides were detected along with minor 
sodium adducts.  The mass spectra corresponding to methyl esterified products obtained 
via both methods revealed the molecular peak of doubly esterified AI [M + H]
+
 at 1324 
Da and AII [M + H]
+
 at 1074 Da as well as their corresponding sodium adducts [M + 
Na]
+
 at 1346 Da and 1096 Da respectively.  There appears to be less formation of singly 
esterified peptide formed when an in-capillary approach was used.  It is entirely possible 
that in contrast to the in-vial reaction, performing the reaction in-capillary generally had 
less exposure to the atmosphere (which might contain water vapor) since two ends of the 
capillary were immersed in anhydrous methanol for the duration of the reaction.  In sum, 
comparable or even better results were obtained for the in-capillary method compared to 
the in-vial method, in consideration of the degree of completeness for methyl 
Anhydrous 
MeOH
Anhydrous 
MeOH
2 M MeOH-HCl
Peptides in 
Anhydrous MeOH
Mixed by Diffusion
In-capillary Incubation
InletOutlet
Injection
Figure 3.x : Schematic of in-capillary methyl esterification with injections of 
alternating bands of methanolic-HCl and peptides dissolved in anhydrous methanol, 
which are subsequently mixed by diffusion and subject to in-capillary incubation.
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esterification.  However, this requires other more quantitative methods for further 
confirmation. 
 
Figure 3.6 mass spectrum obtained after 1 h of in-capillary methyl esterification.  
Peptides AI and AII were at a concentration of 2 μg/mL.  Esterification sites are labeled 
in blue color in the peptide sequences with “m” representing the addition of methyl 
groups. 
3.3.1.3 On-Capillary-Tip Hanging Droplet Reaction 
The idea of performing an on-capillary-tip methyl esterification was derived from 
the complete mixing of reactants in a miniaturized manner.  The MALDI mass spectrum 
resulting from the on-capillary-tip hanging droplet method is shown in Figure 3.7.  Only 
very low esterification ratio was reached due to the observation of predominant peaks of 
underivatized AI and AII at m/z 1296 and m/z 1046, with second predominant peaks of 
singly methyl esterified AI and AII at m/z 1310 and m/z 1060 and very low intensities of 
the fully derivatized products.  This approach appears to be a lot less effective with 
respect to the formation of fully esterified products, in comparison to either the in-vial or 
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the in-capillary trial.  A reasonable explanation is that the airtightness was still poor 
although the droplet was kept in a capped vial for the duration of the reaction.  As has 
been stated before, if water is present in the reaction, acid chloride can react with it to 
reform a carboxyl group.  Thereby, with exposure to the moisture in the atmosphere, the 
completeness of the esterification was tremendously impaired.  Another plausible reason 
is the evaporation of the esterifying agents, especially the volatile hydrochloride in 
MeOH-HCl.  Although measures were taken to prevent solvent evaporation of the 
hanging droplet such as keeping an enough amount of methanol in the sealed vial to form 
saturated vapor, there seemed to be less effective esterifying ability for this set-up.  As a 
consequence, new methods have to be developed for effective esterification at the 
capillary tip. 
 
Figure 3.7 MALDI mass spectrum obtained after 1 h of on-capillary-tip hanging droplet 
methyl esterification.  Peptides AI and AII were at a concentration of 0.02 mg/mL.  
Esterification sites are labeled in blue color in the peptide sequences with “m” 
representing the addition of methyl groups. 
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3.3.2 Completeness of Methyl Esterification with Variant Reaction 
Times 
For methyl esterification some procedures reported conversion to fully esterified 
product in less than 1 h with side product and sample degradation occurring with longer 
reaction times.
17
  Others reported longer reactions sometimes followed by evaporation of 
the reaction mixture and repeating the reaction.
4, 5
  It is of importance to investigate the 
efficiency of the derivatization procedure by studying the reaction proceeding as a 
function of reaction time. 
3.3.2.1 In-Vial Reaction Time 
In this work, esterification efficiency for both model peptides and peptide 
mixtures from β-casein tryptic digest was investigated in both in-vial and in-capillary 
approaches, respectively.  The in-vial reaction was performed using model peptides AI 
and AII with variant reaction time: 20 min, 40 min, 60 min and 2 h.  With a fast reaction 
rate, after 20 min there was no starting material for both AI and AII, and peak 
representing the full esterification products appeared (MALDI mass spectra not shown).  
It seems that after 1 h the reaction has gone to completion and increased reaction times up 
to 2 h did not result in an enhancement of the fully esterified peptide signals.  This short 
period of time for the esterification to proceed may be attributed to either the small sizes 
of the model peptides (8 to 9 amino acid residues) or the limited sites for esterification. 
It has been proposed in previous studies that peptides with only a few sites for 
esterification take less time to fully esterify while peptides which are larger and have 
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more possible sites for esterification take more time and potentially several rounds of 
esterification.
9
  Figure 3.8 shows the in-vial methyl esterification result for the 
monophosphopeptide ([M + H]
+
 m/z 2061) from β-casein tryptic digest after 1 h of 
reaction time.  Interestingly, even in the presence of seven carboxylic groups as possible 
esterification sites in its sequence FQ(pS)EEQQQTEDELQDK (labeled in blue color), 
the reaction goes to completion with majorly septuply esterified products ([M + H]
+
 m/z 
2160) a limited presence of the sextuply esterified peak ([M + H]
+
 m/z 2146) within a 
short period of reaction time (1 h).  Therefore, the esterification efficiency might not be 
simply related to either peptide size or number of esterification sites, or even being an 
integrated outcome of several factors including hydrophobicity and isoelectric point (pI). 
 
Figure 3.8 Enlarged MALDI mass spectrum of the monophosphopeptide 
FQ(pS)EEQQQTEDELQDK (m/z 2061.82) after 1 h of in-vial methyl esterification.  
Peptides obtained from β-casein tryptic digest were at a concentration of 0.04 mg/mL.  
Esterification sites are labeled in blue color in the peptide sequences with “m” 
representing the addition of methyl groups. 
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3.3.2.2 In-Capillary Reaction Time 
The reaction efficiency was also gauged for the in-capillary approach, and for 
model peptides AI and AII, the in-capillary method appears to follow the same trend as 
the in-vial method (data not shown).  A preliminary conjecture can be derived from this 
relatively high reaction rate, that the difference in reaction times is likely contributed by 
the number of carboxyl groups in the starting material.  To take one step further, the in-
capillary approach was also tested on a peptide mixture obtained from β-casein tryptic 
digest, which provides a relatively wide range of peptides including a phosphopeptide in 
which our special interest lies. 
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Figure 3.9 Enlarged profiles of MALDI mass spectra of six in-capillary methyl esterified 
peptides from β-casein tryptic digest: (A) GPFPIIV (m/z 742.45); (B) AVPYPQR (m/z 
830.45); (C) YPVEPFTER (m/z 1137.55); (D) LLYQEPVLGPVR (m/z 1383.65); (E) 
FQ(pS)EEQQQTEDELQDK (m/z 2061.82); (F) DMPIQAFLLYQEPVLGPVR (m/z 
2186.16).  Sample concentration was 0.04 mg/mL.  Esterification results with variant 
reaction time of 20 min, 40 min and 60 min were examined.  Esterification sites are 
labeled in blue color in the peptide sequences with “m” representing the addition of 
methyl groups, and deamidation sites are labeled in red color. 
 As is shown in the above series of mass spectra for six selected peptides from β-
casein tryptic digest, in-capillary methyl esterification was successfully conducted to 
acquire mostly fully esterified products for the major peptides along with some side 
products and salt adducts during MALDI ionization.  Compared to the in-vial method, 
there seems to be less formation of side products resulting from deamidation on amide-
containing amino acid side chain.  However, even increasing the concentration to 0.04 
mg/mL, there were a few peptides that could not be detected using the in-capillary 
method, possibly due to low abundances and poor ionization efficiency caused by 
ionization suppression from abundant peptides.  Peptide GPFPIIV ([M + H]
+
  m/z 742.5) 
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showed no signal of underivatized peak only after 1 h of reaction time (Figure 3.9 A).  
As illustrated by Figure 3.9 B, for peptide AVPYPQR ([M + H]
+
 m/z 830.5), 
esterification went to completion for all the carboxylate moieties and that negligible 
traces of the underivatized peptides were present after 1 h, with a mass shift of 15 Da as 
the deamidation product on the Q residue.  Peptide YPVEPFTER ([M + H]
+
  m/z 1137.6) 
also displayed a high conversion rate with only small amount of doubly esterified 
products and considerably high signal of fully esterified peak after 1 h of reaction time 
(Figure 3.10 C).  However, peptide LLYQEPVLGPVR ([M + H]
+
 m/z 1383.6) presents 
an incomplete conversion to its fully esterified products and significant signal of the 
doubly esterified products with a mass shift of 15 Da as an indication of the deamidation-
methyl esterification reaction occurring at the amide group of the Q residue (Figure 3.9 
D).  Peptide DMPIQAFLLYQEPVLGPVR ([M + H]
+
 m/z 2186.2), the corresponding 
fully esterified product at m/z 2228.2 was observed, together with the detection of a 
doubly esterified peak of minor intensity at m/z 2214.2 (Figure 3.9 F).  However, the 
underivatized signal and the sodium adducts were detected as well, and high-intensity 
peaks of the deamidation products were observed at m/z 2243.2.  The fully methyl 
esterified monophosphopeptide, however, was only detected as its sodium adducts at m/z 
2181.9 (Figure 3.9 E). 
A list of our studied peptides from β-casein tryptic digest is shown as follows in 
Table 3.4, with the calculation their pIs, number of esterification sites and number of 
amino acid residues.  It has been a preliminary assumption that esterification rate is 
attributed to peptide size, peptide abundance, pI, hydrophobicity or other possible factors 
such as differences of MALDI MS ionization efficiencies.  The in-capillary timed 
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reaction, however, illustrated scattered results for the derivatized peptide fragments, 
indicating that the esterification efficiency is probably a peptide-dependent outcome.  For 
some peptides higher conversion rate can be obtained in a short amount of time, but for 
other peptides, longer reaction time or repeated esterification only give rise to more side 
deamidation or oxidation products.  The optimization of the overall esterification 
efficiencies for a peptide mixture is to some degree governed by the peptides’ properties. 
Table 3.4 A list of peptides commonly identified from the tryptically digested β-casein, 
in the increased order of calculated pI. 
Peptide Sequence [M + H]
+
 
Calculated 
pI 
Number of 
Esterification Sites 
Number of 
A.A Residues 
RELEELNVPGEIVE(pS)L(pS)
(pS)(pS)EESITR 
3122.26 1.37 8 25 
FQ(pS)EEQQQTEDELQDK 2061.82 3.29 7 16 
FQSEEQQQTEDELQDK 1981.56 3.77 7 16 
DMPIQAFLLYQEPVLGPVR 2186.16 4.37 3 19 
YPVEPFTER 1137.55 4.48 3 9 
GPFPIIV 742.45 5.52 1 7 
HQGLPQEVLNENLLR 1759.94 5.62 3 15 
LLYQEPVLGPVR 1383.65 6.00 2 12 
EAMAPK 646.32 6.10 2 6 
EMPFPK 748.37 6.10 2 6 
VLPVPQK 780.49 8.72 1 7 
AVPYPQR 830.45 8.79 1 7 
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3.3.3 Effect of Methyl Esterification on MALDI Ion Detection Mode 
Previously we have demonstrated the results of performing in-capillary methyl 
esterification on phosphopeptides, mass spectra recorded in negative ion mode show 
lower abundances of multiply charged species, lower background, higher reproducibility, 
and, thus, overall cleaner spectra compared with positive ion mode spectra.
18
  It has been 
has demonstrated in a preceding study that the conversion of carboxylic groups to their 
corresponding esters is contributive to the improved detection of the modified 
counterparts.
19
  The negative ion mode for MALDI MS identification of phosphopeptide 
showed advantageous over the positive ion mode after derivatization of the carboxylate 
groups by methyl esterification.  Additionally, methyl esterification displayed the 
tendency to increase MALDI detection of the modified protonated peptide ions.  In 
negative mode, esterification tends to exert a deleterious effect on the ion yield of the 
corresponding deprotonated species. 
To elucidate whether modifications of the acidic character of peptides prevent 
formation of anionic species under MALDI analysis, comparison can be made between 
the mass spectra obtained from both positive and negative modes. Comparing the mass 
spectra derived from the methyl esterified products of β-casein tryptic digest, there are 
less observable peaks in the MALDI negative ion mode (data not shown).  Although 
phosphorylated peptides of β-casein produced peptide signals with higher relative 
abundance, the protein sequence coverage was lower in negative ion mode compared to 
that of the positive ion mode.  This is explainable since non-phosphorylated peptides 
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contain a positively charged lysine or arginine at the C-terminus as well as a positively 
charged amino terminus. 
However, there is no evidence that in the negative (or positive) mode, methyl 
esterification can contribute to signal enhancement of the phosphorylated species.  This is 
not matched up with previously published work which demonstrated that with peptide 
esterification on the proteolytic digest of phosphoproteins, negative ion detection in 
MALDI can provide a distinct advantage over the positive ion mode of operation for 
phosphopeptide analysis, even without IMAC enrichment.
10
 
3.3.4 On-Capillary-Tip Sample Recovery 
The next step is to explore a method to recapture target peptide inside the 
capillary, and hopefully to preconcentrate the broad plug into a narrow band for 
enrichment purpose.  In our lab, a discontinuous buffer system has been developed to 
perform partial IEF separation of peptides resulting from in-capillary tryptic digestion 
prior to MALDI-MS analysis.  In addition to the dynamic pH junction for sample 
stacking, solid phase extraction is also an exciting method especially the usage of 
superparamagnetic particles.  In a microanalytical method reported by Rashkovetsky et 
al., magnetic beads (MBs) were used in combination with CE instrumentation.
20
  A short 
plug of MBs can be localized into the capillary and held fixed by an external magnet.  
Ideally, by adopting capillary-located MBs, target peptides could be captured at specific 
conditions and eventually contribute to an in-capillary trapping.  Nevertheless, the 
presence of esterifying reagent used can be extremely problematic to these two 
prospective approaches.  Therefore, a better method has to be developed in order to 
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increase the compatibility of this in-capillary methyl esterification system to the aqueous 
environment for subsequent sample enrichment. 
For the in-vial experiment, in order to dry down the esterified products to 
complete dryness, either SpeedVac or lyophilization approach can be adopted, while for 
the in-capillary reactions (incubated/mixed), the situation becomes more complicated.  
Considering the anhydrous environment required for a high conversion rate of the 
esterification, drying the capillary contents has to be performed with much care.  
Moreover, the re-introduction of the sample inside the capillary as a narrow band for 
subsequent analysis remains also another issue of importance.  A new design is therefore 
proposed here to remove the unwanted organic solvents (MeOH-HCl) from the system.  
In this approach, after the reaction reaches completion, high pressure (1 bar) is applied to 
flush the entire capillary contents into a hanging droplet, which can be directly dried at 
the capillary tip by a flow of N2 gas.  After complete removal of any remanent solvent, a 
droplet of buffer (1 µL) was directly pipetted onto the capillary tip and sat for 30 s, and 
the peptide recovery were evaluated in MALDI MS using recovery buffers (Figure 3.10).  
In consideration of the compatibility with MBs-based sample enrichment as well as the 
feasibility of establishing a dynamic pH-junction for preconcentration, four different 
composition was chosen for the recovery buffers/solutions: 50% acetonitrile (ACN), 1% 
TFA, 10 mM pH 9 ammonium acetate (AmAc), 50% ACN in 10 mM pH 9 AmAc.  The 
results were listed in Table 3.5 (MALDI MS raw data not shown). 
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Figure 3.10 Schematic of on-capillary-tip droplet sample recovery test. 
Table 3.5 Peptides identified from the tryptically digested β-casein recovered from the 
on-capillary-tip using four types of recovery solutions. 
Peptide Sequence [M + H]
+
 Control 
Recovery Buffer (Solution) 
50% 
ACN 
1% TFA 
10 mM 
pH 9 
AmAc 
50% ACN in 10 
mM pH 9 AmAc 
AVPYPQR 830.45 ✓ ✓ ✓ ✓ ✓ 
VLPVPQK 780.5 ✓ 
  
✓ ✓ 
EAMAPK 646.32 ✓ 
    
EMPFPK 748.37 ✓ 
 
✓ ✓ 
 
LLYQEPVLGPVR 1383.65 ✓ ✓ ✓ ✓ ✓ 
HQGLPQEVLNENLLR 1759.94 ✓ ✓ ✓ ✓ ✓ 
GPFPIIV 742.45 ✓ 
    
YPVEPFTER 1137.55 ✓ ✓ ✓ ✓ ✓ 
DMPIQAFLLYQEPVLGPVR 2186.16 ✓ ✓ ✓ ✓ ✓ 
FQSEEQQQTEDELQDK 1981.56 
     
FQ(pS)EEQQQTEDELQDK 2061.82 ✓ ✓ ✓ ✓ ✓ 
RELEELNVPGEIVEpSLpSpS
pSEESITR 
3122.26 
     
 
Attempts to detect the tetraphosphorylated peptide peak ([M + H]
+
 m/z 3122) 
without any preconcentration and enrichment were not successful in all of the samples, in 
N2 Flow
Recovery Buffer: 1 μL
Pressure
Sample Droplet: 1 μL
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large part due to ion suppression from other abundant peptides, as well as poor ionization 
efficiency resulting from both large size (>3000 Da) and the presence of multiply 
phosphorylated sites.  The monophosphorylated peptide ([M + H]
+
 m/z 1961) was 
observed in all samples with variant intensities.  Overall speaking, most of the peptides 
from β-casein tryptic digest can be recovered using the four selected recovery buffer 
regardless of the presence of organic phase (ACN) or specific salts (AmAc) or acidity 
(TFA), which might result from the low retention of the fused silica surface after 
removing the polyimide coating.  This is desirable because the possibility of choosing 
various recovery buffer solutions can contribute to the flexibility of this system for the 
hyphenation to other procedures.  As is shown by Figure 3.11, up to 60~90% MS 
intensity recovery was obtained within the mixture of peptides from β-casein tryptic 
digest by using 10 mM pH 9 AmAc as the recovery buffer, indicating the feasibility of an 
on-line coupling with this system to an in-capillary enrichment or that the capturing 
ability of MBs can be tested in this recovery buffer for a range of peptides.  Although 
MALDI-MS is not a qualitative technique as the degree of sample ionization account for 
the observed signal intensity, which can be affected by a number of factors such as 
crystallization, sample dryness, degree of acidity, and the MS instrumental parameters, 
the recovery ratio still provides some insight into the feasibility of integrating our in-
capillary methyl esterification and on-capillary tip solvent removal steps with sample 
recapture and enrichment.  With this desirable recovery of peptides using aqueous buffers, 
the proposed scheme of on-capillary-tip sample recovery followed by recapturing the 
recovered sample inside the capillary can be tested in the near future. 
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Figure 3.11 MALDI MS results of on-capillary-tip droplet sample recovery test on β-
casein tryptic digest with the magnified window showing the MS signal of the 
monophosphopeptide FQ(pS)EEQQQTEDELQDK (m/z 2061.82): (A) control; (B) 
recovered sample.  Peptides obtained from β-casein tryptic digest were at a concentration 
of 0.04 mg/mL.  10 mM pH 9 AmAc was used as the recovery buffer. 
3.4 Conclusions 
Both in-vial and in-capillary methyl esterification were performed in a 
comparison of reaction effectiveness and efficiency.  Undoubtedly, advantages of the in-
capillary method over the in-vial method were evidenced by the largely reduced sample 
consumption and higher detection sensitivity.  In this work, an in-capillary methyl 
esterification method was developed as a miniaturized derivatization scheme for the 
detection of phosphopeptides.  Nevertheless, in order to use esterification as an effective 
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analytical methodology of phosphopeptide followed by MS analysis, there are still 
prerequisites side reactions such as oxidation should be avoided or minimized to reduce 
spectral complexity.  With regards to the enhanced identification of phosphorylated 
peptides, enrichment step is also included.  By taking advantage of the in-capillary 
reaction combined with preconcentration by a dynamic pH junction or peptide recapture 
enable by magnetic beads (MBs), an integrated procedure can hopefully be developed.  
However, to come up with this, the compatibility of the methyl esterification system to 
the aqueous environment usually used in pH junction or sample enrichment by MBs has 
to be addressed.  An easy way of solvent removal particularly for methyl esterification 
was investigated in this work by conducting on-capillary-tip sample recovery test.  The 
results indicated that the next step of sample enrichment can be integrated into the system. 
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Chapter 4. Conclusions and Future work 
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4.1 Conclusions 
Chapter 1 presented efforts towards instrumental analysis of ADP-ribosylation by 
CE, with an essential focus on ARTD-10 cat.  The hypothesis of an unsuccessful in vitro 
mono-ADP-ribosylation attempt was preliminary raised on the basis of CE experimental 
results.  The MALDI-MS data was also a good supplement to our evidence, denoting no 
sign of ADP-ribosylation modification on the sample.  Subsequently, the interactions 
between DTT and ARTD-10 cat, potentially disulfide bridge(s) by reduction, were 
revealed by peak shifts observed in CE analysis.  This finding was underpinned by the 
same pattern of band shifts in reducing as well as non-reducing GE by using another 
reducing agent BME.  Collectively, these data indicate that the attempts for ADP-
ribosylating ARTD-10 were not successful.  We also confirmed that DTT was accounted 
for both Tm differences in CE and band shifts in GE, which were resulted from reduction 
of the disulfide bridge(s) in ARTD-10 cat.  However, there existed some observations 
that could not been explained so far, such as the double peak of ARTD-10 cat presented 
at pH higher than 5 and the observed 200 Da smaller MW in MS compared to the 
theoretical MW.  This work has brought some light on the analysis of ARTD-10, yet a 
substantial amount of work is going to be done to fully resolve the PARP biochemistry. 
In addition to high-efficiency separation, sample preparation accounts for an 
important branch in CE applications.  Due to MS ionization suppression, 
phosphopeptides have to be enriched or derivatized in order to obtain reasonably good-
quality signals.  Methyl esterification is usually performed to block the acidic amino acid 
side chains in the phosphorylated species to reduce non-specific sample binding in IMAC.  
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In this work, both in-vial and in-capillary methyl esterification were performed and 
reaction effectiveness and efficiency were evaluated.  Undoubtedly, advantages of the in-
capillary method over the in-vial method were evidenced by the largely reduced sample 
consumption and higher detection sensitivity.  In order to use esterification as an effective 
analytical methodology of phosphopeptide followed by MS analysis, there are still 
prerequisites side reactions such as oxidation should be avoided or minimized to reduce 
spectral complexity.  With regards to the enhanced identification of phosphorylated 
peptides, enrichment step is also included.  By taking advantage of the in-capillary 
reaction combined with preconcentration by a dynamic pH junction or peptide recapture 
enable by magnetic beads (MBs), an integrated procedure can hopefully be developed.  
However, to come up with this, the compatibility of the methyl esterification system to 
the aqueous environment usually used in pH junction or sample enrichment by MBs has 
to be addressed.  An easy way of solvent removal has also been investigated in this work 
by conducting on-capillary-tip sample recovery test.  The results indicate that the next 
step of sample enrichment can be integrated into the system. 
4.2 Future Work 
To identify and characterize the inter- or intra-molecular disulfide bridges in the 
intact protein structures, digestions have to be performed under non-reducing conditions, 
followed by MS or MS/MS analysis.  Major tasks include the identification of the 
number of disulfide bonds, the localization of the inter- or intra-molecular disulfide 
linkages, and also hopefully the characterization of the 3D structures of ARTD-10 cat.  
On the other hand, the ease of integrating sample pretreatment directly in-capillary 
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represents a unique feature of CE for realizing high-throughput and low-cost analyses, 
where the capillary can serve as preconcentrator, desalter, microreactor, chiral selector 
and simulator.
1
  Among the diverse functionalities, online techniques such as in-capillary 
derivatization or sample stacking have both been reported as effective methodologies for 
enhancing the detection sensitivity.  The combination of these two techniques can result 
in a more powerful alternative which does not require extra equipment.
2
  To develop an 
online-preconcentration system in CE using dynamic pH junction, or immobilized MBs 
to fufill in-capillary sample enrichment task, are the two basic directions for the future 
work in the CE sample preparation for the analysis of protein/peptide phosphorylation. 
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Appendices 
Appendix A: General remarks on linear mode and reflectron mode for the TOF mass 
analyzer 
TOF mass analyzers separate accelerated ions based on the differences between their 
velocities.  The operating principles of TOF mass analyzers are elegantly simple.  For this 
method, an ion is given a fixed amount of kinetic energy by acceleration in an electric 
field that is generated by the application of a high voltage.  Following acceleration, the 
ion enters a field-free region where it travels at a velocity that is inversely proportional to 
its m/z.  Because of this inverse relationship, ions with low m/z travel more rapidly than 
ions with high m/z.  In a TOF mass analyzer, a "pulse" (or "bundle") of ions is 
accelerated out of the source by a reasonably high voltage in a vacuum tube, and the ions 
are then allowed to drift in the field-free region to the detector.  The ions all have 
identical kinetic energies and thus the heavier ions travel slower than the lighter ions.  
Thus the separation of the ions is dependent on their respective “flight time”, namely the 
length of time for each ion to travel along the flight tube before reaching the detector.  
This is achieved by the ions with smaller masses arriving at the detector faster than ions 
with larger masses i.e. ions with smaller mass will have a shorter "flight time".  A time 
signal is initiated when the ions are pulsed out of the ion source and also when they arrive 
at the detector, so that the time of flight can be measured, which is proportional to the 
square root of its m/z value.  The larger the mass of a singly charged ion, the longer it 
takes to travel through the field-free region.  Essentially, TOF mass analyzer has an 
unlimited mass range, and hence can be ideally applicable to analyzing polymeric 
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materials as well as large biological molecules.  TOF mass spectrometers can be typically 
classified into two broad categories, linear and reflector-type instruments. 
 
In the linear mode, MALDI-TOF analyzer works in such a simple way that the 
time of flight is measured as the time it takes for a specific ion to fly from one end to the 
detector.  The linear mode often suffers from poor resolution for continuous ion 
extraction, due to the relatively broad distribution of initial velocities.  That is, when 
analytes with the same m/z ratio are ionized their kinetic energies are not necessarily 
identical.  If the acceleration potential would be continuously turned on, such that the 
ions are accelerated instantaneously upon being formed, the ions with the same m/z value 
but with different momentum reach the detector at slightly different times, resulting in 
peak broadening.  To resolve this, delayed ion extraction is usually employed in linear 
TOF to enhance mass accuracy over a broad mass range by focusing velocity distribution 
with the optimal time lag.  Delayed extraction refers to a delay in the onset of the 
acceleration potential by a short time after the ionization has occurred.  The delay time 
acts as a focusing element, which will lead to simultaneously detection of the ions, due to  
acceleration in the ionization chamber.  Delayed extraction is often used in MALDI ion 
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sources, due to the focusing effect.  In view of the resolution issue, linear TOF is usually 
used for the analysis of proteins or large peptides. 
 
In order to improve the resolving power of TOF instrument, reflectron, an ion optic, 
mirror-like device in the ion acceleration region can be used to reflect ions of the same 
m/z values that have different energies.  Ions with greater kinetic energies penetrate 
further into the reflection than those with smaller kinetic energies.  The ions that 
penetrate further also spend a longer time in the reflectron, and thus take longer to reach 
the detector.  The overall effect is that the reflectron decreases the spread in the flight 
times for ions of the same m/z ratio but different kinetic energies, and therefore 
resolution and mass accuracy are both improved.  TOF instruments using delayed 
extraction and reflectron ion optics with high data acquisition speeds to give an m/z 
resolution greater than 10,000, will provide mass accuracies in the 5- to 20-ppm range.  
As a whole, reflectron TOF instruments typically present much higher resolution and 
mass accuracy than their linear counterparts: reasonable resolution of the isotopes is 
obtained in the case of reflectron TOF analysis, compared with a single averaged peak in 
the case of the linear mode. 
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Appendix B: Calculated total net charges for the unmodified form and modified (mono-
ADP-ribosylated) form of ARTD-10 cat under different pH conditions. 
 
Unmodified pyrophosphate group Modified 
pH Charge pKa1=0.91 pKa2=2.10 Charge 
0 41 -0.1095494 -0.00788 40.88257 
0.25 41 -0.1795048 -0.01393 40.80657 
0.5 41 -0.280081 -0.0245 40.69542 
0.75 41 -0.4089244 -0.04276 40.54832 
1 41 -0.5516235 -0.07359 40.37479 
1.25 41 -0.6863003 -0.12377 40.18993 
1.5 40.9 -0.7955199 -0.20076 39.90372 
1.75 40.9 -0.8737104 -0.30876 39.71753 
2 40.8 -0.9248272 -0.44269 39.43248 
2.25 40.7 -0.9562892 -0.5855 39.15821 
2.5 40.5 -0.9749402 -0.71525 38.80981 
2.75 40.2 -0.9857516 -0.81708 38.39717 
123 
 
3 39.7 -0.9919372 -0.88818 37.81988 
3.25 39 -0.9954499 -0.93389 37.07066 
3.5 37.9 -0.9974362 -0.96171 35.94085 
3.75 36.3 -0.9985566 -0.9781 34.32334 
4 34.1 -0.9991878 -0.98757 32.11324 
4.25 31.3 -0.9995431 -0.99297 29.30749 
4.5 28.2 -0.999743 -0.99603 26.20422 
4.75 25.3 -0.9998555 -0.99777 23.30238 
5 22.8 -0.9999187 -0.99874 20.80134 
5.25 20.9 -0.9999543 -0.99929 18.90075 
5.5 19.3 -0.9999743 -0.9996 17.30042 
5.75 17.8 -0.9999855 -0.99978 15.80024 
6 16.1 -0.9999919 -0.99987 14.10013 
6.25 14.2 -0.9999954 -0.99993 12.20008 
6.5 12.1 -0.9999974 -0.99996 10.10004 
6.75 10 -0.9999986 -0.99998 8.000024 
7 8.1 -0.9999992 -0.99999 6.100013 
7.25 6.6 -0.9999995 -0.99999 4.600008 
7.5 5.5 -0.9999997 -1 3.500004 
7.75 4.4 -0.9999999 -1 2.400002 
8 3.4 -0.9999999 -1 1.400001 
8.25 2.2 -1 -1 0.200001 
8.5 1 -1 -1 -1 
8.75 -0.3 -1 -1 -2.3 
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9 -1.6 -1 -1 -3.6 
9.25 -3 -1 -1 -5 
9.5 -4.6 -1 -1 -6.6 
9.75 -6.5 -1 -1 -8.5 
10 -8.5 -1 -1 -10.5 
10.25 -10.6 -1 -1 -12.6 
10.5 -12.5 -1 -1 -14.5 
10.75 -14.2 -1 -1 -16.2 
11 -15.8 -1 -1 -17.8 
11.25 -17.6 -1 -1 -19.6 
11.5 -19.9 -1 -1 -21.9 
11.75 -22.7 -1 -1 -24.7 
12 -25.9 -1 -1 -27.9 
12.25 -29 -1 -1 -31 
12.5 -31.7 -1 -1 -33.7 
12.75 -33.7 -1 -1 -35.7 
13 -35 -1 -1 -37 
13.25 -35.8 -1 -1 -37.8 
13.5 -36.3 -1 -1 -38.3 
13.75 -36.6 -1 -1 -38.6 
14 -36.8 -1 -1 -38.8 
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Appendix C: Reconstitution of different reagents for CE peak assignment. 
 
Appendix D: Conditions of ART assay on hARTD-10. 
Lyophilized/TCA-precipitated sample 
+NAD
+
 
Incubated with β-NAD+, 
30 °C, 3 h. 
–NAD+ 
Incubated without β-NAD+, 3 h; 
Was not kept in ART-buffer. 
 
ART-buffer 
50 mM pH 8 sodium phosphate 
1 mM DTT 
4 mM MgCl2 
 
Acid urea gel 
Resolving 
gel 
15% acrylamide 
0.9 N acetic acid 
2.5 M urea 
Stacking gel 7.5% acrylamide 
 
(A) 
unmodified 
ARTD10 cat 
(B) 
NAD
+
 + 
(A) 
(C) 
glycerol + 
(A) 
(D) DTT 
+ (A) 
(E) 
HEPES + 
(A) 
(F) 
MgCl2 + 
(A) 
1 M HEPES, pH 7 - - - - 2 µL - 
80% glycerol - - 4 µL - - - 
1 M  MgCl2 - - - - - 0.2 µL 
0.5 M DTT - - - 0.4 µL - - 
40 mM  NAD
+
 - 2.5 µL - - - - 
water 15 µL 12.5 µL 11 µL 14.6  µL 13 µL 14.8 µL 
ARTD10 cat, ~5mg/mL in 
50 mM pH 4.5 ammonium 
acetate 
5 µL 5 µL 5 µL 5 µL 5 µL 5 µL 
Tm 2.234 min 
2.230 
min 
2.234 min 
2.212 
min 
2.101 
min 
2.233 
min 
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0.375 M potassium acetate, pH 4 
2.5 M urea 
 
Appendix E Acid urea SDS-PAGE image of ART assay on hARTD-10 obtained by two 
desalting methods. 
Lyophilization TCA precipitation 
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Appendix F: Non-reducing and reducing GE images for ARTD-10 cat samples. 
Non-reducing GE images: (A) incubation mixture of 2 mM DTT and ARTD-10 cat; (B) 
untreated ARTD10 cat (for CE analysis); (C) negative control 2 (–NAD+); (D) stock 
solution of untreated ARTD-10 cat from the Shilton Lab.  Reducing GE images for 
ARTD-10 cat samples: (E) negative control 2 (–NAD+); (F) treated ARTD-10 cat 2; (G) 
stock solution of ARTD-10 cat from the Shilton Lab; (H) untreated ARTD-10 cat (for CE 
analysis); (I) diluted negative control 2 (–NAD+). 
A B C D E F G H I 
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